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Abstract
The advent of high-throughput Next Generation Sequencing technologies
that generate information about the genome, transcriptome and epigenome
has created a demand for the development of statistical approaches to detect
biological phenomena that occur on a molecular level. One of those phenom-
ena is intragenic initiation, which corresponds to transcription initiation in
an exon downstream of the first.
The aim of this thesis is to apply statistical methods to identify intragenic
initiation and to use these to study the e↵ect of down-regulation due to
mutation in the SETD2 gene, a putative tumor suppressor gene in clear cell
renal cell carcinoma.
We analyzed count data from a RNA-seq experiment, a Next Generation
Sequencing method to obtain the transcriptome of a cell, to detect intragenic
initiation in six cell lines: two controls and four cell lines with loss of function
mutations in the SETD2 gene. Our approach was based on transforming the
data into proportions and comparing pairs of proportions either using the
two proportions comparison test along with the Benjamini-Hochberg proce-
dure to correct for multiple testing or the Marascuilo procedure, a method
that performs every pair-wise comparison in an experimental unit and incor-
porates correction for multiplicity.
Our results showed that the two proportions comparison method was not
able to e↵ectively detect intragenic initiation since very few genes were de-
tected that had no relation with genes detected by the Marascuilo procedure
and other published data. The Marascuilo procedure, on the other hand, de-
tected 1304 genes with approximately 300 genes per mutant sample. There
was 50% overlap between at least two mutant cell lines, which suggests that
the method is consistent.
We conclude that the Marascuilo procedure seems to be a method that
can be applied to the detection of intragenic initiation and allows detection
iii
of this phenomenon in each of the cell lines individually.
Keywords: Next Generation Sequencing (NGS), Intragenic initiation,
Proportion comparison, Multiple testing, Marascuilo Procedure.
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Resumo
Nos u´ltimos anos observou-se um enorme desenvolvimento no campo da
sequeˆnciac¸a˜o gene´tica com o desenvolvimento das plataformas de elevada
produc¸a˜o de Next Generation Sequencing (NGS). Com a tecnologia de NGS
e´ poss´ıvel sequenciar um genoma ou um transcriptoma por completo em ape-
nas horas ou dias, o que constitui um avanc¸o importante quando comparado
com os me´todos de sequenciac¸a˜o de Sanger. A plataforma de NGS e´ baseada
na fragmentac¸a˜o e amplificac¸a˜o atrave´s de PCR de DNA ou RNA em pe-
quenos segmentos, denominados reads, e na selec¸a˜o das reads que alinham
com um genoma de refereˆncia. Estas, denominadas reads mapeadas , sa˜o
selecionadas para ana´lise e estudo de feno´menos a n´ıvel molecular celular.
O desenvolvimento destas tecnologias foi acompanhado da necessidade de
desenvolver ferramentas de bioinforma´tica para analisar dados de NGS. Estas
ferramentas sa˜o indispensa´veis para traduzir e estudar feno´menos gene´ticos
a partir dos dados na˜o processados obtidos a partir dos aparelhos de se-
quenciac¸a˜o. Um aspecto importante da NGS e´ a possibilidade de estudo de
feno´menos a n´ıvel do genoma e do transcriptoma versus ao n´ıvel de genes
e prote´ınas individualmente. Neste trabalho em particular, e´ de salientar a
possibilidade de estudar o feno´meno de iniciac¸a˜o intrage´nica da transcric¸a˜o,
que corresponde a` iniciac¸a˜o da transcric¸a˜o de DNA em RNA mensageiro
num exa˜o que na˜o o primeiro (que corresponde ao local usual de in´ıcio da
transcric¸a˜o).
Recentemente, o gene SETD2 foi identificado como sendo um poss´ıvel
gene supressor de tumor em linhas celulares de carcinoma renal de ce´lulas
claras. Este gene codifica uma histona metiltransferase responsa´vel pela
trimetilac¸a˜o da lisina 36 da histona H3 (H3K36me3). E´ ja´ sabido que a
auseˆncia de expressa˜o de SETD2 resulta em instabilidade de microssate´lites
e num aumento da taxa de mutac¸a˜o, motivo pelo qual se associa a reduzida
expressa˜o de SETD2 ao cancro. Adicionalmente, a H3K36me3 mediada pelo
SETD2 parece estar associada a alterac¸a˜o dos padro˜es de splicing e a um
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aumento da iniciac¸a˜o intrage´nica.
O objectivo deste trabalho e´ aplicar me´todos estat´ısticos para identificar
iniciac¸a˜o intrage´nica da transcric¸a˜o e usar os mesmos para estudar o efeito
da mutac¸o˜es de SETD2 neste feno´meno usando linhas celulares de carcinoma
renal de ce´lulas claras.
Neste trabalho foram aplicados dois me´todos de detec¸a˜o de iniciac¸a˜o in-
trage´nica que foram aplicados em dados provenientes de seis linhas celulares
de carcinoma renal de ce´lulas claras: quatro linhas celulares com mutac¸o˜es
loss of function do gene SETD2 (AB, ER, MF e FG2) e duas linhas-controlo
(Caki1 e Caki2). Primeiro, foi efetuado o processamento dos dados origina-
dos pelo aparelho de sequenciac¸a˜o para obter dados de contagens relativos ao
nu´meros de reads que alinharam com cada exa˜o. Estes dados foram trans-
formados em proporc¸o˜es tendo como base as contagens de reads e numa
estimativa do nu´mero de reads que existiriam se todos os exo˜es tivessem o
mesmo n´ıvel de expressa˜o e se comportassem como um gene activo. O ob-
jectivo foi comparar a expressa˜o entre todos os pares de exo˜es contiguous
em cada gene e seleccionar os genes com um n´ıvel de expressa˜o superior por
parte de um exa˜o que na˜o o primeiro, o que sugere a existeˆncia de iniciac¸a˜o
intrage´nica da transcric¸a˜o.
Para cada linha celular, obteve-se um vector com as proporc¸o˜es de ex-
pressa˜o de cada exa˜o organizadas por gene e foram aplicados dois me´todos
estat´ısticos que podem ser usados para comparac¸a˜o mu´ltiplas proporc¸o˜es:
(1) o teste de comparac¸a˜o de duas proporc¸o˜es e (2) o me´todo de Marascuilo.
No me´todo (1) foram efetuadas todas as comparac¸o˜es dois-a-dois entre os
pares de exo˜es cont´ıguos de cada gene e, um vez que se tem comparac¸o˜es
mu´ltiplas, os valor-p obtidos foram ajustados usando o procedimento de
Benjamini-Hochberg que controlo a proporc¸a˜o de verdadeiras hipo´teses nulas
em cada gene. No me´todo (2) foi aplicado um me´todo que efetua todas as
comparac¸o˜es dois-a-dois entre os exo˜es de cada gene e selecionados os pares
de interesse (ou seja, os pares de exo˜es cont´ıguos). Este me´todo testa mais
pares do que o necessa´rio levando a um maior nu´mero de comparac¸o˜es. Isto
cria um vie´s na direc¸a˜o da hipo´tese nula o que faz deste procedimento um
me´todo conservador. No entanto, o me´todo de Marascuilo tem a vantagem
de incorporar a correc¸a˜o para testes mu´ltiplos na˜o sendo necessa´rio aplicar
um outro me´todo para efetuar esse ajuste.
Na nossa abordagem, um gene tem iniciac¸a˜o intrage´nica da transcric¸a˜o
se satisfizer os seguintes crite´rios: (1) apresentar um exa˜o downstream com
maior n´ıvel de expressa˜o que o primeiro exa˜o (ou primeiros exo˜es), (2) o
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primeiro exa˜o diferencialmente expresso positivamente encontrar-se nos primeiros
40% dos exo˜es do gene e (3) mantiver os n´ıvel de expressa˜o em 50% dos exo˜es
downstream do primeiro exa˜o diferencialmente expresso.
Utilizando o nosso algoritmo de processamento de dados foram identi-
ficados 42233 genes, excluindo isoformas, dos quais 13667 (⇡31.7%) foram
exclu´ıdos por serem compostos por apenas quatro exo˜es ou menos. Optou-se
por excluir estes genes a priori visto ser imposs´ıvel os mesmos obedecerem
aos crite´rios de iniciac¸a˜o intrage´nica estabelecidos.
Os nossos resultados mostraram que o teste de comparac¸a˜o de duas pro-
porc¸o˜es juntamente com o procedimento de Benjamini-Hocherg na˜o consegiu
identificar um nu´mero satisfato´rio de genes. Adicionalmente, os genes iden-
tificados na˜o apresentavam qualquer concordaˆncia com os detectados com o
me´todo de Marascuilo e com dados previamente publicados. Foi colocada
a hipo´tese deste aspecto se dever a` sensibilidade para este me´todo detectar
pequenas flutuac¸o˜es de expressa˜o por ser um me´todo menos conservador do
que o me´todo de Marascuilo, bem como ao facto dos crite´rios para considerer
iniciac¸a˜o intrage´nica serem estritos.
Por outro lado, o me´todo de Marascuilo, detectou 1304 genes com ini-
ciac¸a˜o intrage´nica tendo identificado cerca de 500 genes em cada amostra.
Destes, ⇡300 genes eram espec´ıficos das linhas celulares mutadas quando
elimiandos os genes concordantes entre cada uma destas linhas e o controlo
Caki1. Pelo contrario, quando eliminados os genes concordantes entre as
amostras Caki1 e Caki2, foram detectados apenas 208 genes nesta u´ltima
amostra, o que vem ao encontro da previsa˜o de que a mutac¸a˜o no gene
SETD2 aumenta a inicic¸a˜o intrage´nica.
Com este trabalho pode-se concluir que o me´todo de Marascuilo pode
ser usado como uma ferramenta para detetar iniciac¸a˜o intrage´nica. Este
me´todo deteta um menor nu´mero de genes que um me´todo menos conver-
vador baseado no teste exato de Fisher previamente descrito, mas apresenta
a vantagem de identificar numa amostra sem necessitar de comparar com
o controlo, ou seja, e´ capaz de detectar a iniciac¸a˜o intrage´nica basal numa
linha cellular controlo, por exemplo. Adicionalmente, este me´todo parece
ser preciso na quantificac¸a˜o de iniciac¸a˜o intrage´nica tendo-se detectado uma
concordaˆncia de 50% entre pelo menos duas linhas mutadas, o que contrasta
com uma concordaˆncia de 22% no me´todo previamente descrito.
Palavras-chave: Next Generation Sequencing (NGS), Iniciac¸a˜o intrage´nica,
Comparac¸o˜o de proporc¸o˜es, Testes mu´ltiplos, Me´todo de Marascuilo.
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Preface
In recent years important developments have occurred in the field of ge-
netic sequencing with the development of high-throughput Next Generation
Sequencing (NGS) technologies. With NGS technology it is possible to se-
quence a whole genome or transcriptome in hours or days, which constitutes
major breakthrough when compared with Sanger sequencing-based methods.
The NGS framework is based on fragmenting and amplifying millions of DNA
or RNA pieces, called reads, and selecting the reads that align with a ref-
erence genome. The reads that align (called mapped reads) are selected for
analysis and study of molecular biology phenomena.
The development of these technologies was accompanied the need to de-
velop bioinformatics tools to analyze NGS data. These tools are indispens-
able to perform research since they work as translators of the raw data pro-
duced by the sequencing machines. An important aspect of Next-Generation
sequencing is that it permits the study of biological phenomena that occur
at the genome or transcriptome level. In particular to this work, it permits
the study of the phenomenon of intragenic transcription initiation, which is
the initiation of transcription of DNA into mRNA starting at an exon other
than the first (the usual location for transcription to start).
Recently, the SETD2 gene has been identified as putative tumor suppres-
sor in cell lines of clear cell renal cell carcinoma, the most common type
of renal cancer. This gene codes for a histone methyltransferase that is re-
sponsible for the trimethylation of lysine 36 of histone H3 (H3K36me3). It
is known that lack of expression of SETD2 in cells results in microsatellite
instability and an elevated mutation rate, which explains the association be-
tween loss of function of SETD2 and cancer. Moreover, SETD2-mediated
H3K36me3 seem to be associated with changes in splicing patterns and in
an increase in intragenic initiation.
The aim of this thesis is to apply statistical methods to identify intragenic
xv
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initiation and to use these to study the e↵ect of down-regulation due to
mutation in the SETD2 gene in this phenomenon.
In this manuscript we applied two methods to detect intragenic initiation
and applied them to six clear cell renal cell carcinoma cell lines: four cell
lines carrying loss-of-function mutations in the SETD2 gene (AB, ER, MF
and FG2) and 2 normal controls (Caki1 and Caki2). First, we processed
the raw data from the RNA-seq experiment in order to obtain read counts
for each exon of each cell line. Then, we transformed the count data into
proportions based on the reads counts of each exon and on an estimate of the
reads counts considering that every exon of every gene has equal expression
and behaves as an active gene. Our goal was to compare the expression
between every pair of contiguous exons and select the genes that showed
significantly higher expression of a downstream exon that suggested that
transcription initiation had occurred at an exon other that the first.
For each cell line, we obtained a vector with exon expression proportions
organized by gene and applied two statistical methods that can be used
to compare multiple proportions: (1) The two proportions comparison test
and (2) the Marascuilo procedure. In (1), we performed all comparisons
between contiguous exons and, since we incur in a problem of multiple testing,
adjusted the obtained p-values using the Benjamini-Hochberg procedure, a
method that controls the False Discovery Rate or the proportion of true
null-hypothesis. In (2), we applied a procedure that performs every pair-
wise comparison between exons in a gene and selected the pairs of consecutive
exons. Testing more pairs than the pairs of interest biases the results towards
the null-hypothesis thus making this a conservative method of detection. The
Marascuilo procedure has the advantage of incorporating the correction for
multiple testing in itself thus not requiring the concomitant use of a method
of correction for multiple testing.
In our approach a gene has intragenic initiation if it satisfies one of the
following criteria: (1) a downstream exon is more expressed than the first
exon/s, (2) the first expressed exon is within the first 40% of the exons in
the gene and (3) the expression of the exons downstream of the first in stable
in at least 50% of those exons. Using our data processing algorithm, we
identified 42233 genes, excluding isoforms, of which 13667 genes (⇡31.7%)
were excluded because they were composed of less than 5 exons. We opted
to exclude these because with our criteria genes with less that 5 exons would
never show intragenic initiation. Our results showed that the two proportions
comparison method was not able to e↵ectively detect intragenic initiation
since very few genes were identified. Moreover, these had no concordance
xvi
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with the genes detected by the Marascuilo procedure and other published
data. We hypothesize that this was due to the number of fluctuations in
expression that this method, being less conservative than the Marascuilo
procedure, can detect allied to the relatively strict criteria to consider that
a gene showed intragenic initiation. The Marascuilo procedure, on the other
hand, identified 1304 genes with approximately 500 genes per sample. Of
these, ⇡300 genes were specific to the mutant cell lines when we eliminated
the genes that we belonged to the intersection between the control Caki1
and each of the mutant cell lines. In contrast, when we eliminated the genes
detected in both Caki1 and Caki2, we identified only 208 genes in Caki2,
which suggests that mutations in SETD2 are associated with an increase in
intragenic initiation.
With this work we can conclude that the Marascuilo procedure can be
used as a tool to detect intragenic initiation. It detects less genes than a
previously described less conservative method using Fisher0s exact test but
has the advantage over the latter of detecting genes in a sample without
requiring it to be compared with a control. In this sense, it detects baseline
intragenic initiation. Additionally, it seems to be an accurate method in
quantifying this phenomenon since it detected a 50% concordance between
at least two mutant samples.
xvii
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Chapter 1
Biological Background
This chapter is meant to introduce the biological framework behind the prob-
lem we want to approach. It provides an overview of concepts of cell and
molecular biology inspired by Cooper and Hausman0s textbook 00The Cell,
a Molecular Approach00 (2007) and the state of the art regarding renal cell
carcinoma and the SETD2 gene, whose e↵ects in the former cells we want to
elucidate. It will also provide a basis of understanding of Next Generation
Sequencing, the technology used to generate the data that will allow us to
answer our proposed question. To finalize, we will present the aims of this
thesis.
1.1 The genome and genes
The genome constitutes the entirety of the hereditary information in a cell.
According to each organism, it is constituted either by deoxyribonucleic acid
(DNA) or ribonucleic acid (RNA). In eukaryotes, the genome is composed of
DNA located in the nucleus of the cells and it is normally divided in several
pieces called chromosomes. Each chromosome is further divided into genes
that constitute the basis of the hereditary information of a cell. Each gene
serves as a template to synthesize RNA through a highly regulated process
known as transcription that consists of a series of steps to obtain processed
RNA (also known as messenger RNA or mRNA). The mRNA then migrates
to the cytoplasm where will be ”read” by the endoplasmic reticulum to pro-
duce proteins, a process known as translation. Even though, the products
of gene expression are the sole responsibles for the phenotype of a cell the
1
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remainder of the genome (also known as non-coding DNA as opposed to the
coding DNA corresponding to genes) plays a very important role in the reg-
ulation of gene expression. In particular, the non-coding DNA is constituted
by regulatory sequences that modulate gene expression (e.g. transcription
activators and inhibitors). Moreover, each chromosome is not simply consti-
tuted by DNA (or RNA). Despite the di↵erences among di↵erent organisms,
eukaryotic chromossomes are also constituted by proteins, called histones,
with the DNA wrapped around them forming a coil-shaped structure. Hi-
stones play a very important role in the regulation of gene expression by
altering their structure in response to certain stimuli (e.g. the methylation
of a particular aminoacid) thus promoting or repressing transcription. In the
same way the genome constitutes the whole of a cell’s genetic information,
the transcriptome is the group of all mRNAs in each cell according to its
pattern of gene expression and the proteome the group of proteins produced
by a cell from mRNA. The latter is normally considered a direct product of
the expression of the transcriptome.
1.2 Transcription
Transcription starts with the synthesis of RNA from a DNA template. This
is mediated by an enzyme called RNA polymerase that binds to DNA and
uses it as a template to synthesize mRNA. RNA polymerase recognizes a
particular region of the gene called the promoter where it binds to start
transcription. Promoters are regions normally located upstream of the gene
that contain specific sequences recognized by RNA polymerase.
After transcription, the mRNA is processed to its final form before mi-
grating to the cytoplasm. In particular, parts of the mRNA, the introns,
are removed to obtain the final mRNA that will be translated (Figure 1.1).
The mRNA fragments that remain, the exons, are ligated to form processed
mRNA. The process of removing introns in named splicing and is a form of
generating transcriptional diversity. Several genes show more the one pat-
tern of intron removal. Therefore, one gene can originate more than one
mRNA and consequently, di↵erent proteins. In general, splicing occurs with
the removal of one particular set of introns. However, under certain circum-
stances, alternative splicing (removal of a di↵erent set of introns) can occur
thus forming alternative spliced isoforms.
Another pathway of generation of transcript diversity is intragenic initi-
ation (ITI). In this situation, RNA polymerase binds to a cryptic promoter
2
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Figure 1.1: Transcription and mRNA processing. RNA poly-
merase synthesizes pre-mRNA from DNA. Pre-mRNA is further processed
and introns are removed to form processed mRNA that will migrate to
the cytoplasm and will serve as a templante to protein synthesis in the
endoplasmic reticulum.
site, that is, a promoter-like site in the gene where RNA polymerase can bind
to initiate transcription (Pattenden et al., 2010). Although these promoters
allow transcription initiation, it is known that their structure is di↵erent from
normal promoters and the exact mechanism of action of RNA polymerase in
this case is yet to be elucidated. Nevertheless, it has been established in yeast
that mutations in certain genes promote intragenic initiation. Specifically,
mutation of components of the Set2-Rpd3S pathway results in cryptic tran-
scription initiation within the coding region of approximately 30% of yeast
genes (Pattenden et al., 2010).
1.3 DNA sequencing and Next Generation
Sequencing
Sequencing is the process of determining the nucleotide order in a sample
of nucleic acids (DNA or RNA). DNA sequencing first started in the early
1970s with the first sequences being obtained using two-dimensional chro-
matography. In 1973, Maxam and Gilbert sequenced the lac operator (24
basepairs) using a method known as wandering spot analysis (Maxam and
Gilbert, 1976). In 1977, Sanger sequenced the first whole DNA genome from
the bacteriophage  X174 (Sanger et al. , 1977(1)). Sanger developed a rapid
3
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Figure 1.2: Alternative splicing. Some exons are alternatively spliced,
that is, they can remain in the mRNA or be removed via splicing. This
mechanism allows the production of di↵erent transcripts and, conse-
quently, proteins, meaning that one gene can code for more than one
proteins. In general, alternative splicing is dependent on the presence of
slicing factors that mediate the removal of each set of introns and alter-
native exons.
DNA sequencing method based on chain-terminating inhibitors (Sanger et
al. , 1977(2)). Later in 1977, Maxam and Gilbert introduced a novel method
based on chemical modification of DNA and cleavage at specific sites (Maxam
and Gilbert, 1977). Maxam and Gilbert’s methods become more popular at
first but were supplanted by Sanger’s method, which was less technically de-
manding and employed less radiation and toxic chemicals than the former
(Saccone and Pesole, 2005).
Sanger’s method was the basis for the methods that followed. These
had the advantage of faster (and cheaper) sequencing due to the possibil-
ity of parallelization. In the late 1980s the first semi-automated and auto-
mated sequencing machines were developed and this jump-started the se-
quencing of whole genomes. In 1995, the first free-living organism genome
from Haemophilus influenzae was sequenced (Fleischmann et al. , 1995).
Later, in 2001, a draft of the human genome was obtained using the shotgun
de novo sequencing approach of the Sanger method (Figure 1.3a) and, by
2004 the complete human genome had been sequenced.
In the mid to late 1990s, Next Generation Sequencing (NGS) was intro-
duced. The ”next-generation” methods allowed whole genome sequencing
significantly faster than the Sanger’s method-based approaches thus opening
4
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the possibility of sequencing whole chromosomes and whole genomes in days.
The next-generation methods are very diverse but their general workflow is
similar (Figure 1.3b): DNA is randomly fragmented and common adapter
sequences are ligated to the ends of each fragment. The fragments are then
spatially separated and will undergo several cycles of PCR amplification. The
amplified fragments will cluster around the original fragment thus forming
”polonies”. The sequence is obtained by alternating cycles of nucleic acid
synthesis via a polymerase or a ligase and imaging to obtain data on each
added nucleotide.
The data used in this work was obtained using the IlluminaR  Genome
Analyzer HiSeq2000. This method is a sequencing by synthesis technology
(SBS) where the adapters are attached by a flexible linker in a plane struc-
ture, known as the flow cell. The DNA fragments are amplified by bridge
PCR (Figure 1.4) and clusters of each fragment are formed in the cell. The
synthesized single-stranded DNA fragments are called reads. This method
forms reads between 75 base pairs (bp) and 100bp and allows mapping of
the whole genome or sequencing of the transcriptome, for example.
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Figure 1.3: Shotgun Sanger sequencing and next-generation se-
quencing. (a) In Sanger’s sequencing genomic DNA is fragmented, cloned
to a plasmid vector and used to transform E. coli. Each colony is used in
a reaction where plasmid DNA is isolated and subject to a ”cycle sequenc-
ing” reaction where cycles of template denaturation, primer binding and
primer elongation take place. The sequence is obtained by high-resolution
electroforetic gel separation of the DNA fragments synthesized from the
genomic DNA templates. An alternative to shotgun Sanger sequencing
that is targeted to a segment of the genome is based on the creation of
DNA fragments and the PCR amplification using specific primers for the
region of interest. Sanger’s sequencing method can then be applied. (b)
In next-generation sequencing methods, genomic DNA is fragmented and
ligated to a set of adaptors that can bind to an array where each DNA frag-
ment will be spatially separated. These fragments are then subject to sev-
eral cycles of amplification generating PCR colonies or ”polonies”. Each
fragment undergoes alternating cycles of DNA synthesis with fluorescent-
labeled nucleotides and imaging to detect each inserted nucleotide. This
approach allows the parallel sequencing of all the fragments in one single
array. Although not all next-generation methods are based on a planar
array, the other methods are all based on the spatial separation of the
fragments and therefore the same principles apply (figure adapted from
Shendure and Hanlee, 2008).
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Figure 1.4: Bridge PCR. Single stranded genomic DNA fragments
bind one of the adapter sequences, bend (or form a bridge) and ligate
the opposite end to a free adaptor in the flow cell. DNA synthesis (am-
plification) takes place in this setting. After amplification the bridge is
dismantled by DNA denaturation and separation of each strand. Several
cycles of amplification and denaturation lead to the formation of single-
stranded DNA fragment clusters (reads), since the adapters are in fixed
locations in the array.
The advent of NGS technologies brought more applications than simple
DNA sequencing. These techniques allow determination of the transcrip-
tome (a method known as RNA-sequencing or RNA-seq), small noncoding
RNA (ncRNA) discovery and profiling, detection of histone modifications
(ChIP-seq) and chromatin interactions (ChIA-PET), DNA methylation pro-
filing (MeDIP-seq) and mapping of nucleosome protected DNA (MNase-seq),
among others (Kim and Yu, 2012).
The data provided for our analysis was RNA-seq data since the biological
goal is to determine the e↵ect of the gene SETD2 in transcriptome alterations
through intragenic transcription initiation.
1.3.1 RNA-seq data analysis
RNA-seq is a NGS method that allows identification and quantification of
all the transcripts in a cell (transcriptome) (Oshlack et al. 2010). Nowa-
days, it is a widely used tool in transcriptomics with several advantages over
microarrays (Ozsolak et al. , 2011) and Sanger sequencing-based methods
like expressed sequence tag (EST) sequencing (Nagaraj et al. 2008). It has
advantages over microarrays because it does not depend on prior knowledge
of the organism’s genome, yields significantly less background noise and has
a single-base resolution (Oshlack et al. , 2010, Wang et al. , 2008 and Mar-
guerat et al. , 2008). In addition, RNA-seq is advantageous relative to EST
sequencing which is relatively low-throughput, expensive and less precise
since only a portion of the transcript is analysed (Wang et al. , 2008). RNA-
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seq is based on the general framework of NGS or high-throughput technolo-
gies. It starts with isolation and purification of RNA from a cell line (Figure
1.5). The RNA is used as a template to synthesize cDNA (complementary
DNA, DNA synthesized from processed mRNA therefore not containing in-
trons) with adaptors attached to one or both ends. Each cDNA fragment
is amplified and sequenced in a high-throughput manner, as previously de-
scribed, to obtain short sequences (reads) of one (single-end sequencing) or
both ends (pair-end sequencing) of the fragment. This method produces
reads with 30-400 bp (75-100 bp with Illumina’s HiSeq 2000 technology)
(Wang et al. , 2008). The number of reads produced with a certain sequence
will be proportional to the number of mRNA molecules present in the cell
thus allowing inference on a cell’s genetic expression profile (Morozova and
Marra, 2008).
The analysis of RNA-seq data can be highly variable according to the
biological question. RNA-seq is mostly used for gene expression profiling
between a wild-type and a mutant samples but it can also be applied to
detect di↵erential allelic expression (Wagner et al., 2010 and Wang et al.,
2008), alternative splicing (Pan et al., 2008 and Sultan et al., 2008) and
fusion genes (Ozsolak et al., 2011 and Maher et al., 2009).
After processing the sample, the high-throughput sequencing platform
generates a file consisting of short sequences (reads) and an associated quality
score (Oshlack et al. 2010). The analysis steps that follow are illustrated
in Figure 1.6. First, the sequences are aligned to a reference genome or
transcriptome. Second, the aligned reads are assembled (or summarized) to
obtain counts of the number of reads that were mapped to each gene, exon
or transcript, according to the goal of the experiment. Third, the data are
normalized to enable accurate comparison of expression between and within
samples. Finally, statistical analysis of di↵erential expression is performed to
attain a list of genes/exons/transcripts with associated p-values from which
a biological insight can be taken.
Normalization is an essential step in the analysis of RNA-seq data and
there are several methods and packages available that standardize read counts.
Normalization methods can be based on Total Counts (TC), on the Upper
Quartile (UQ), Median (Med) or on the calculation Reads Per Kilobase per
Million mapped reads (RPKM) (Dillies et al., 2013). Additionally, the are
packages whose function is to perform normalization like EDASeq (Risso et
al., 2011) and packages that incorparate normalization tools like DESseq and
edgeR (Anders and Huber, 2010). These packages are open source and avail-
able at Bioconductor (http://www.bioconductor.org). In our case, we
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opted to use the simple method of converting read counts to RPKM, spe-
cially because in previous with the data used the same normalization method
was applied.
Figure 1.5: RNA-seq experiment. After isolation of RNA from a cell,
the mRNA molecules are fragmented and used as templates to synthesize
cDNA which is attached to adaptors and amplified (the cDNA is used
as the genomic DNA fragments in a standard DNA sequencing experi-
ment). The cDNA extremities are sequenced, generating short reads. In a
single-end sequencing experiment only one end of the cDNA is sequenced
(since only one adaptor is attached to the cDNA) whereas in a paired-end
experiment, both ends are sequenced as represented in the figure.
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There are several available software products (based on di↵erent ap-
proaches which go beyond the scope of this manuscript) to perform each
of the described steps. Given the potential and quality of NGS technolo-
gies, the analysis of high-throughput data is hot topic in biostatistics and
bioinformatics research with new techniques and software’s being developed
at a very fast rate. In chapter 2, we will further discuss some techniques
of statistical analysis of di↵erential expression (DE) used in this setting and
present the methods used in our analysis.
Figure 1.6: RNA-seq workflow. The output of the sequencer is a
.fastqc file that contains the sequences of each read. The first step is to
align the reads to a reference genome or transcriptome available in online
databases using software’s like Tophat, Bowtie or BWA that use di↵erent
methods of alignment. Second, the data is summarized at gene, exon or
transcript level in order to obtain count data regarding the number of
reads that aligned with each unit. Bedtools is on open-source available
software that transforms .sam or .bam files that contain aligned reads
in count data files in the .bed format. These data can be analyzed using
statistical software to test for DE, for example.
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1.4 Clear cell renal cell carcinoma and the
SETD2 gene
Renal cell carcinoma (RCC) is the most frequent type of kidney cancer. It
originates in the epithelial cells of the proximal convoluted tube of the kid-
ney and corresponds to approximately 3% of all human malignancies (Jemal
A, Cancer Statistics 2009). According to the World Health Organization
there are three histological subtypes of renal cell carcinoma: clear cell RCC
(ccRCC), papillary RCC (pRCC) and chromophobe RCC (chRCC) (Eble et
al. , 2004). The ccRCC is the most frequent subtype, corresponding 80%-
90% of all renal cell carcinomas.
Several genetic alterations have been associated with RCC. In particular,
mutations in the Von Hippel-Lindau (VHL) gene, chromosome 3p translo-
cation and mutations in the succinate dehydrogenase B (SDHB) gene have
been shown to play a role in the pathogenesis of ccRCC (Cancer Genome At-
las Research Network, 2013). Mutations in the VHL tumor suppressor gene
account for 60% of the sporadic ccRCC and are also associated with the
Von Hippel-Lindau disease, an autosomal dominant genetic disorder char-
acterized by retinal angiomas, hemamgioblastomas of the central nervous
system, pheochromocytomas and ccRCC. Moreover, translocations in chro-
mosome 3p have been associated with ccRCC in part because the VHL gene
is involved. However, translocations involving other regions of chromosome
3p, namely 3p21 also seem to be involved in the pathophysiology of ccRCC
thus suggesting the presence of other tumor suppressor genes in that region.
Recently, Duns et al. have identified the SETD2 gene as putative tumor
suppressor in cell lines of ccRCC with 3p21 copy number loss. The SETD2
gene, the human counterpart of the Set2 gene from yeast, codes for a histone
methyltransferase that is nonredundantly responsible for the trimethylation
of lysine 36 of histone H3 (H3K36me3). Lack of expression of SETD2 in
cells results in microsatellite instability and an elevated mutation rate which
explains the association between loss of function of SETD2 and cancer (Li et
al. , 2013).
SETD2-mediated H3K36me3 is also associated with changes in transcrip-
tion. Misteli et al. showed that histone modifications like H3K36me3can alter
splicing patterns. More recently, it has been shown that SETD2 modulates
FACT (FAcilitates Chromatin Transcription) and inhibits initiation of tran-
scription at cryptic promoter sites (Carvalho et al. , 2013). In addition,
analysis of sequencing data from a SETD2 deficient cell line showed an in-
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crease in intragenic initiation, which is the initiation of transcription at a
cryptic promoter rather than the usual promoter site, in at least 11% of the
active genes (Carvalho et al. , 2013). The aim of this work is to create an
algorithm to detect intragenic initiation using count data from an RNAseq
experiment with SETD2 deficient cells from six ccRCC cell lines.
1.5 Objectives
In the present work, we want to develop a method to identifiy genes with
intragenic initiation using data from a RNA-seq experiment. The purpose
of this is to help elucidate the function of the SETD2 gene using cell lines
of ccRCC that contain this mutation and compare them to normal controls.
The biological hypothesis behind this is that loss of function of the SETD2
gene will increase the amount of intragenic initiation. Our method will be
based on transforming RNA-seq data into proportions and using two meth-
ods of comparison of proportions within each sample. After implementing
these methods and obtaining results, we will compare them with the results
obtained by Carvalho et al., 2013.
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Statistical analysis of RNA-seq data aims to identify the genes, exons or
transcripts that are di↵erentially expressed between samples (Oshlack et al.,
2010). In addition, these methodologies permit identification of di↵erent pat-
terns of expression (isoforms) between samples due to intragenic initiation
and alternative splicing. There are several methods used in the analysis of
di↵erential expression of RNA-seq data which can be divided in paramet-
ric and non-parametric methods. Some have been incorporated into user-
friendly packages that facilitate the analysis (e.g. edgeR (Robinson et al.,
2010), DEGseq (Wang et al., 2010)).
Despite the fact that the methods of analysis of RNA-seq can detect
di↵erences in expression of a gene, exon or transcript individually, they are
not designed to detect more complex phenomena like intragenic initiation and
alternative splicing which depend on patterns of expression between each unit
and a deep understanding of cell biology in order to model them.
In this chapter, we will present the basis for statistical hypothesis testing,
a cornerstone in almost every statistical tool, the methods used in the sta-
tistical analysis of RNA-seq data and the background behind our proposed
approach to detect intragenic initiation of transcription.
2.1 Statistical Inference
Statistical inference is the process of extracting conclusions from datasets
containing observations from random variables. Since it is generally impossi-
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ble to observe all the units/individuals in a population, statistical inference
extrapolates conclusions using a representative sample of the population,
given a certain degree of uncertainty.
One way of drawing conclusions from the data is by recurring to hypoth-
esis testing. This approach implies simplifying the problem by dichotomiz-
ing it into two complementary hypotheses: the null hypothesis, H0 and the
alternative hypothesis, H1. The null hypothesis is a claim contradictory
to what we aim to prove and, naturally, the alternative hypothesis corre-
sponds to the claim we believe is true and want to prove. The hypothe-
ses are set as equalities or inequalities about parameters of the popula-
tion like the expected value, the variance or the distribution of the pop-
ulation. For example, let X be the height of an individual in a popula-
tion. If we want to show that the average height, E(X ) = µ, in a popula-
tion is di↵erent from 170 cm, the hypotheses would be formulated like this:
H0 : E(X ) = 170 vs. H1 : E(X ) 6= 170.
After establishing the hypotheses, we must make assumptions about the
data, like the distribution of the random variable of interest and/or the in-
dependence of the observations, and calculate a value for the test statistic.
The observed value of the test statistic is calculated from the data assuming
that the null hypothesis is true. A statistically significant result corresponds
to rejecting the null hypothesis in favor of the alternative hypothesis. To de-
fine if a result is statistically significant, we must determine a critical value
and compare it to the value of the test statistic that will allows us to decide
whether or not to reject H0. If the observed test statistic exceeds the critical
value, H0 is rejected and we consider the alternative hypothesis H1, which is
usually what we want to prove.
Since we are inferring information about a population using only a sample,
our conclusions may be incorrect due to chance. Therefore, when perform-
ing a statistical test we can commit two errors: reject the null hypothesis
when it is true or fail to reject the null hypothesis when H1 is true. These
mistakes correspond to the type I and type II errors, respectively. In fact,
the probability of type I error is strictly related with the critical value since
the later corresponds to the 1  ↵2 quantile (in case of bilateral tests) of the
distribution of the random variable being considered.
Statistical inference can be used to test hypotheses related with gene ex-
pression. The simplest question a molecular biologist can ask is what is the
di↵erence in expression of gene A between two cell types. In this regard, we
can apply statistical hypotheses testing and formulate the following hypothe-
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ses: H0 : Gene A is equally expressed between the two cells types vs. H1 :
Gene A is di↵erentially expressed between the two cell types. This is one pos-
sible application of statistics to the analysis of genetic data. However, many
other applications exist, that span from gene expression, to protein structure
and to epigenetics. Here we emphasize the applications of statistics in the
analysis of NGS data.
2.2 Statistical analysis of di↵erential expres-
sion of RNA-seq data
RNA-seq data is essentially count data of each experimental unit, whether it
is a gene, exon or transcript. Therefore, the parametric methods used need
to be able to model low count data of a small number of samples, which is
generally the case with NGS experiments. The most common parametric
methods used in RNA-seq data analysis are based on the Poisson and neg-
ative binomial distributions (Oshlack et al., 2010). The binomial negative
distribution can be seen as a generalization of the Poisson distribution (in
which the mean equals the variance). In the binomial negative distribution
the variance can be modeled separately which may be required in experi-
ments with a small number of replicates to avoid type I errors (Anders and
Huber, 2010). Several statistical analysis packages implement methodolo-
gies based in these two distributions: edgeR, DEGseq, DESseq (Anders and
Huber, 2010), DEXseq (Anders et al., 2012) and bayseq (Hardcastle et al.,
2010). All these packages are open source and available at Bioconductor
(http://www.bioconductor.org).
Fisher’s exact test has been used as a non-parametric method to detect
di↵erential expression (DE) (Wang et al., 2008, Brooks et al., 2010). It is
used in the statistical analysis of 2x2 contingency tables and can be applied
in RNA-seq data analysis to compare each exon between samples (Table 2.1).
In addition, to Fisher’s exact test two other non-parametric methods
used to analyze RNA-seq data are cu↵di↵ (Trapnell et al., 2010) and NOISeq
(Tarazona et al., 2011). The first method in based on the cu✏inks framework
adapted to the detection of DE. Cu↵di↵ builds a table with the expected vari-
ance of each condition taking into account the amount of reads that aligned
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Table 2.1: Applying Fisher’s exact text to detect DE. Fisher’s
test is can be used to compare the levels of expression of the same exon
between samples (control vs. mutated sample). Repeating this procedure
for each pair of consecutive exons between samples allows for detection of
intragenic initiation.
Control Sample
Exoni Read counts Read counts
Total Mapped Reads TotalMappedReadscontrol TotalMappedReadsmutant
with an experimental unit across all the replicates. Cu↵di↵ then estimates
how many reads originated from each experimental unit and queries the table
for the variance of that unit. Additionally, it takes into account read mapping
uncertainty as happens with reads aligning in splice site junctions. NOISeq
estimates the ”noise distribution” which takes into account the sample vari-
ability within the same condition before testing for DE between samples with
di↵erent conditions (controls vs. mutant cell lines, for example).
Few methods used in the analysis of microarray data have been adapted to
RNA-seq analysis. Microarray data are treated as continuous measurements
and, consequently, are modeled by continuous distributions (e.g. normal
distribution, gamma distribution) (Soneson et al., 2013). On the other hand,
NGS data are count data (sometimes low-count) and thus inherently follow a
discrete probability distribution. Nevertheless, the limma (Smyth GK, 2004)
method has been adapted through data transformation to RNA-seq data
analysis and two limma-based methods exist: voom(+limma) (Smyth et al.,
2004 and Soneson et al., 2013) and vst(+limma) (Smyth et al., 2004 and
Anders and Huber, 2010).
2.3 Detection of Intragenic Initiation
Fisher’s exact test has been used to detect intragenic initiation in a SETD2-
deficient ccRCC cell line (Carvalho et al., 2013). By applying Fisher’s test
to assess DE between exons in each sample as previously exemplified, this
method detects intragenic initiation by comparing the results for every pair
of consecutive exons in each gene. So, a gene is said to have intragenic
initiation if at least the first exon is not di↵erentially expressed and the
downstream exons show DE, meaning that transcription started after the
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first exon. This method does not provide information regarding the genes
that have intragenic initiation in the control (and whether they show the
same behavior in the experimental sample). It only detects the genes that
show di↵erential intragenic initiation between samples.
Here we propose a di↵erent approach where we transform count data in
proportions and consider the problem of comparing a series of proportions
in a sample (and the associated problem of multiple statistical inferences).
Moreover, we present the Marascuilo Procedure, a method of comparison of
multiple proportions that corrects for the problem of testing multiple infer-
ences in a sample.
2.3.1 Comparison of multiple proportions
The comparison of multiple proportions can be achieved by using a test to
compare two proportions and repeating it for every pair of proportions. Let
Ak be a random variable defined by the number of reads that align to gene
k. We know that Ak follows a binominal distribution and, since the sample
size is high, we can approximate its distribution to the standard normal
distribution under the central limit theorem. The hypotheses tested for each
exon of gene k are the following: H0 : p1 = p2 vs. H1 : p1 6= p2, where p1 is
the number of reads that align with exon 1 and p2 is the number reads that
align with exon 2. The test statistic Z, under H0, is given by:
Z = pˆ1 pˆ2q
pˆ1(1 pˆ1)
n1
+
pˆ2(1 pˆ2)
n2
⇠ N(0, 1)
For each test the probability of falsely rejecting the null hypothesis is
↵, but if we consider k independent tests, this probability will be larger
and is given by 1   (1   ↵)k. Considering ↵ = 0.05, when we perform 100
independent tests there is a 0.994 probability that at least one test results
in a wrong conclusion. This problem occurs frequently when conducting a
study where several hypotheses are tested using one dataset. This is known
as the problem of multiplicity or multiple testing and occurs whenever a set
of statistical inferences are considered simultaneously. For example, if the
expected value of the height of a population in 170 cm and we test the afore
mentioned hypotheses about X (H0 : E(X ) = 170 vs. H1 : E(X ) 6= 170),
at a significance level ↵ = 0.05, using 100 independent samples, our expected
value of wrong rejections is 5. So, in 5 out of 100 tests, we would arrive to a
false claim.
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In our case, to detect intragenic initiation we incur in a problem of mul-
tiple testing since we want to compare all pairs of consecutive exons of each
gene in a cell. Therefore, a method to correct our p-values so that we do
not erroneously reject the null hypothesis is warranted. There are several
approaches to p-value correction of which the most simple and frequently
used models are the Family-Wise Error Rate (FWER) and the False Discov-
ery Rate (FDR). A very commonly used method is the Benjamini-Hochberg
procedure, which models the FDR. The FWER models are more conservative
which is why we chose a the BH procedure since it allows for more hypothesis
to be rejected and the detection of more genes with intragenic initiation.
The Benjamini-Hochberg procedure
The Benjamini-Hochberg (BH) procedure is based on the estimation of the
FDR which is the fraction of erroneously rejected null hypotheses (also known
as ”false discoveries”) over the number of tests performed.
Benjamini and Hochberg (1995) consider the following model: Let m be
the number of hypotheses being tested,m0 the number of true null hypotheses
and R an observable random variable that corresponds to the number of
hypotheses rejected (table 2.2). U , V , T and S are unobservable random
variables, where U corresponds to the true negatives, V to the false positives
or false discoveries (type I error), T to the false negatives (type II error) and
S to the true positives or true discoveries.
Table 2.2: Modelling the false discovery rate To model the FDR,
Benjamini and Hochberg (1995), consider thatm is the number of hypoth-
esis being tested and m0 is the number of true null hypothesis. V and S
are random variables corresponding to the number of falses positives and
true positives, respectively. V and S are used to calculate the proportion
of null hypothesis erroneously rejected, Q. The FDR is the expectation of
Q.
Considered
non-significant
Considered
significant
Total
True H0 U V m0
Non-true H0 T S m m0
m R R m
The proportion of null hypotheses erroneously rejected, Q, is a random
variable given by Q = VV+S and the FDR or Qe is the expectation of Q:
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FDR = Qe = E(Q) = E(
V
V+S ) = E(
V
R ).
When V + S = 0, Q = 0 since no hypothesis can be falsely rejected.
The BH procedure controls the FDR at a predetermined significance level
↵ and works as follows:
1. Consider m hypotheses tests H1, . . . , Hm and their corresponding p-
values P1, . . . , Pm.
2. Order the p-values from lowest to highest, P(1), . . . , P(m)
3. Find the largest k such that P(k)  km↵
4. Reject all the hypotheses Hi, i = 1, . . . , k whose p-values P(i) satisfy
the condition P(i)  P(k).
This procedure is valid considering m independent hypotheses. Very fre-
quently however, this assumption is not correct since there is a dependence
structure between observations. In our case, we are comparing the expres-
sion among exons of the same gene and these observations are therefore
correlated at the gene level. We need to consider this structure when cor-
recting for multiplicity. To cope with problems like this some alterations
have been introduced to the Benjamini-Hochberg procedure that consider
a dependence structure between the hypotheses (Benjamini and Yekutieli,
2001; Hu et al., 2010). In particular, Hu et al. (2010) developed the grouped
Benjamini-Hochberg procedure which we will discuss.
False discovery rate control with groups
In multiple hypothesis testing, assuming independence between hypotheses
may not translate the true structure of the data and may lead to erroneous
results. A way adopted by several authors has been assigning weights to the
hypotheses (or p-values) to create group structure (Efron, 2008; Genovese et
al., 2006 and Kang et al., 2009). More recently, Hu and colleagues (2010)
proposed the grouped Benjamini-Hochberg (GBH) where FDR control is
achieved by weighing p-values.
The GBH procedure is an extension to the classic Benjamini-Hochberg
(BH) procedure where the m hypotheses being tested can be individualized
into K disjoint groups with sizes ng, g = 1, . . . , K.
In fact, when using the GBH procedure, we can consider two scenarios:
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the oracle case, where the true proportion of null-hypotheses is known and
the adaptive process, where this proportion is unknown and the proportion
of true null hypotheses in each group is estimated by d⇡g,0. In the oracle case,
the GBH procedure works as follows:
1. For each p-value in group g, calculate the weighted p-values, Pwg,i =
⇡g,0
⇡g,1
Pg,i, where ⇡g,0 is the proportion of true null hypothesis in group g, ⇡g,1
is the proportion of true alternative hypothesis in group g and Pg,i is the
p-value associated with the ith ordered element of each.
2. If ⇡g,0 = 1, accept all the hypotheses for that group and Pwg,i = 1. If
⇡g,0 = 1 for every g, then accept all null hypotheses for all groups and stop
the procedure. Otherwise, perform the next steps.
3. Pool all the weighted p-values Pwg,i and order them from lowest to
highest Pwg,(1)  ...  Pwg,(N).
4. Find:
k = max{i : Pwg,(i)  i↵
w
N }, where ↵w = ↵1 ⇡g,0
5. If such a k exists, reject the k null hypotheses associated with Pwg,(1) 
...  Pwg,(k). Otherwise, do not reject any of the hypotheses.
In practice, however, the true proportion of null hypotheses in each group
is not known and it must be estimated (d⇡g,0). There are several methods used
to estimate the proportion of null hypotheses of which the most emblematic
are: the Least Slope (LSL) estimator (Benjamini and Hochberg, 2000), the
Two-Stage (TST) method (Benjamini et al., 2006) and Storey tail proportion
of p-values method (Storey et al., 2004). Here, we will only specify the LSL
estimator which performs well in situations with a sparse signal, that is, with
few rejected null hypotheses (Benjamini and Hochberg, 2000) which is our
case.
The estimation of ⇡g,0 follows two steps (Hu et al. , 2010):
1. Compute lg,i =
(ng+1 i)
1 Pg,(i) . As i increases, stop the first time the condition
lg,i > lg,i 1 is met.
2. Calculate the LSL estimator for each group given by:  LSLg = min
⇣ blg,ic+1
ng
, 1
⌘
The adaptive GBH can now be performed by replacing ⇡g,0 with  LSLg .
This procedure has been implemented in the R package StructSSI (Sankaran,
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2010) which we will use in our analysis in the next chapter.
2.3.2 The Marascuilo procedure
The Marascuilo procedure is a statistical method that compares multiple
proportions pair-wise and permits the identification of the pairs that are
significantly di↵erent. The procedure incorporates the correction for multiple
tests thus avoiding the need to use a p-value correction method.
The hypotheses tested in the Marascuilo procedure are: H0 : p1 = p2 =
. . . = pm vs. H1 : 9i, j i 6= j : pi 6= pj. Considering k samples, of sizes
ni (i = 1, 2, ..., k), the first step is to calculate the test statistics which are
given by the di↵erences between each pair of proportions pi pj, i 6= j. Then,
critical values, rij are calculated for each pair from:
rij =
q
 21 ↵,k 1
vuutpi(1  pi)
ni
+
pj(1  pj)
nj
(2.1)
The critical values are compared to the test statistics. If at least one
absolute value of the test statistic |pi   pj| exceeds the critical value the
null hypothesis is rejected and we conclude there is a significant di↵erence
between samples i and j. By calculating rij using a  2 distribution with k 1
degrees of freedom, the Marascuilo procedure incorporates the correction for
multiple tests. Here we use the Marascuilo procedure as statistical method to
identify intragenic initiation. This approach is slightly di↵erent from most
RNA-seq analysis methods that normally compare each experimental unit
between samples. Both the Marascuilo Procedure and the test of comparison
of multiple proportions with an associated p-value correction method will be
applied to a set of RNA-seq data from ccRCC cells carrying mutations in the
SETD2 gene with the purpose of elucidating the role of SETD2 in intragenic
initiation.
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Method Description and
Results
This chapter is a description of the implementation of the statistical methods
described in the previous chapter and the results obtained after applying
these methods. It starts with a description of the data and data processing
performed followed by a detailed description of the data. We then present
a detailed description of how we applied each method - the two proportions
comparison test and the Marascuilo procedure - and the results obtained.
The steps described here translate the contents of the scripts that are
attached to this manuscript (Appendix A).
3.1 Data Description and Processing
The data used in our analysis was RNA-seq data produced by Se´rgio de
Almeida Lab at Instituto de Medicina Molecular (IMM). Six ccRCC cell lines,
2 SETD2 wild-type cell lines (Caki1 and Caki2) and 4 lines carrying knock-
out mutations in the SETD2 gene (AB, ER, FG2 and MF) were analyzed.
As previously mentioned, sequencing data was obtained with the Illumina R 
Genome Analyzer HiSeq2000 (Bentley et al., 2008).
The procedure for data analysis followed the workflow depicted in Figure
1.6. We were granted access to raw data in .fastqc format and used TopHat
version 2.0.9 (Trapnell et al., 2012) to map high-throughput sequencing reads
to the reference human genome (hg19) (Deszer et al., 2012). Reads mapping
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to multiple locations were excluded. We used BEDTools version 2.17.0 (Quin-
lan and Hall, 2010) to obtain count data for each exon. The data obtained
was analyzed using R version 3.0.2 for Mac OS X.
The steps of data transformation and analysis were as follows (Figure
3.1):
1. Identification and exclusion of genes with 4 or less exons. Con-
sidering genes that have few exons will increase the number of false positives
in our approach. Intragenic initiation relies upon assuming that at least the
first exon is not expressed, that transcription starts in a downstream exon
and expression is stable after that exon. We opted to exclude genes with
few exons in order to avoid misclassification of genes due to exon number.
A gene with few exons is more likely to obey to the criteria we used that
includes a maintenance of higher expression of the downstream exons after
intragenic initiation (ITI).
2. Normalization. We normalized the data by converting reads counts
to reads per kilobase of transcript per million reads mapped (RPKM) as de-
scribed by Mortazavi et al., 2008. To nornalize read counts we used the
following formula:
RPKM = 10
9 ·Number of mapped reads
Totalmapped reads ·Exon length in kilobase pairs
This step is essential to ensure that expression levels between exons are
comparable since without normalization, read counts are proportional to the
number of base pairs in an exon and total number of reads mapped for each
sample.
3. Selection of transcriptionally active genes. We excluded the
bottom third (first tercile) of genes with less expression as genes that were
not transcriptionally active . Genes on the upper third (third tercile) of
expression were considered to be ”very active”, that is, highly expressed.
Expression of a gene was calculated as the sum of normalized read counts of
the exons of a gene.
4. Estimating reads counts based on the more active genes. To
calculate proportions of gene expression, we calculated the expected number
of reads for each exon assuming that all the genes are equally active and in
the ”very active” group. The estimated read counts were normalized, in order
to obtain one single value for the estimated read counts across all exons.
5. Calculating proportions of gene expression. The estimated read
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counts were used (denominator) to calculate the normalized proportion of ex-
pression of each exon. Some of the genes for each sample showed proportions
that were greater than 1 thus making them not amenable to be analyzed
with our proposed methods. The few genes in this group were transfered to
a new matrix and were analyzed separately.
Figure 3.1: Data processing workflow.
After applying these steps, we obtained a vector with proportions of ex-
pression of each exon for each of our six samples. The two proportion com-
parison test and the Marascuilo procedure, described below, used these as
the input for data analysis.
3.2 Samples and data processing
After processing the data using TopHat and BEDTools, two commonly used
software tools in NGS data analysis, we transferred the data to R and built
the data matrix represented in Table 3.1.
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Table 3.1: Raw Data Matrix The data matrix with non-normalized
counts was obtained by importing to R the .bed file generated by BED-
Tools. This file also contains data with a gene tag, chromosome and exon
number for each gene. This data was parsed to columns in our matrix.
Additionally, we matched the gene name to each tag based on the human
genome (hg19) annotation available at UCSC Genome Browser (Kent et
al., 2002) and added an index in order to perform our analysis by gene.
gene exon chromossome caki1 caki2 rccab rccer rccmf rccfg2 gene name index
NM 032291 0 chr1 86 67 7 147 1 0 SGIP1 1
NM 032291 1 chr1 52 38 5 104 2 0 SGIP1 1
NM 032291 2 chr1 37 17 1 82 0 0 SGIP1 1
... ... ... ... ... ... ... ... ... ... ...
NM 012425 0 chr10 28970 26891 20143 6718 9797 12766 RSU1 21101
NM 012425 1 chr10 6625 5979 3737 1532 2162 3060 RSU1 21101
NM 012425 2 chr10 6681 5933 3468 1499 2053 2977 RSU1 21101
NM 012425 3 chr10 5894 5370 3152 1296 1842 2674 RSU1 21101
... ... ... ... ... ... ... ... ... ... ...
Following our data processing algorithm, we identified 42233 genes, ex-
cluding isoforms, of which 13667 genes (⇡31.7%) were excluded because they
were composed of less than 5 exons.
The raw counts of the remaining 28566 genes were normalized and were
used to calculate proportions of expression for each exon. In all samples,
we identified a small subset of very active genes that had at least one exon
with proportions greater than one. The number of genes in each sample that
belong to this subgroup is represented in Table 3.2. The di↵erences are due
to the di↵erent patterns of expression across samples but in all cases this
corresponds to a small subset of genes.
Table 3.2: Genes with proportions greater than 1 For each sample
the number of genes with proportions greater than 1 is displayed. These
correspond to a very small subset of genes comparing to the number of
genes that was analyzed. For each sample, the genes with a pattern sug-
gestive of ITI were selected.
Sample Genes with proportions >1 Genes with possible ITI
Caki1 10 ’SPP1’, ’AKR1B1’, ’VIM’, ’GAPDH’, ’RPL13’
Caki2 7 ’VIM’, ’GAPDH’, ’RPL13’
AB 7 ’SPP1’, ’RPL17’
ER 14 ’ENO1’, ’SPP1’, ’NPM1’, ’ALDOA’, ’RPL17’
MF 8 ’HLA-B’, ’VIM’, ’PSAP’, ’RPL17’
FG2 12 ’ENO1’, ’SPP1’, ’TGFBI’, ’VIM’, ’RPS24’, ’GAPDH’
These genes were eliminated from the analysis of proportions because
the methods implemented can only handle proportions in the interval [0, 1].
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Curiously, some of these genes showed a pattern suggestive of intragenic
initiation, where the proportion of a downstream exon was higher than the
expression of the upstream exon/s (Table 3.3).
Since these genes are a small subset of expression outliers, we performed
an analysis ”by hand” to detect the genes that had a pattern suggestive of
intragenic initiation. The criteria for selection of these genes was:
(1) Existence of several proportions > 1 (more than half of the number
of exons) and the first exon/s with lower expression
or
(2) Few proportions > 1 (less than half of the number of exons), several
proportions with levels within 0.25 of the proportions > 1 and the first exon/s
with lower expression.
The sum of the number exons with proportions > 1 and the number of
exons within 0.25 these had to correspond to at least half the number of
exons in the gene. The gene GAPDH is an example of the application of
criterion (1). After identifying and isolating these genes, the estimated read
counts for the remaining genes were recalculated in order to translate the
expected read counts unbiased by the genes with proportions greater than
one.
Table 3.3: Expression pattern of two genes with ITI and pro-
portions greater than 1.
Gene ID Gene Expression proportion
NM 001256799 GAPDH 0.000463
NM 001256799 GAPDH 1.468526
NM 001256799 GAPDH 1.541777
NM 001256799 GAPDH 1.434993
NM 001256799 GAPDH 1.542627
NM 001256799 GAPDH 1.904736
NM 001256799 GAPDH 1.129369
NM 001256799 GAPDH 0.780231
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3.3 Detection of intragenic initiation
3.3.1 Two proportions comparison test with the grouped
Benjamini-Hochberg procedure
The two proportions comparison test was applied considering each exon as
a unit grouped at the gene level. We compared all pairs of contiguous exons
of each gene (for a gene with j exons, j   1 comparisons were made) and
obtained a set of p-values uncorrected for multiple testing. For gene i with
j exons, our null-hypothesis was H0 : pi,1 = pi,2 = . . . = pi,j.
After calculating a p-value for each pair-wise comparison, we applied
the grouped Benjamini-Hochberg procedure. As previously mentioned, our
group structure was defined at the gene level. However, a large number of
groups as occurs with our data leads to non-rejection of H0 in all cases and
all the weighted p-values are set to be infinite. This occurs because the GBH
procedure assigns a value of ”-Inf” (where ”Inf” stands for infinity) when
the proportion of true null hypothesis in a group is 1. Given our very large
number of genes (or groups), the estimated proportion of H0 is 1 thus not
allowing the use of this p-value correction method.
Due to this and similarly to Carvalho et al., 2013, we assumed no hier-
archical structure and the standard BH procedure was applied. After cal-
culating the p-values and establishing significance assuming a type I error
probability of 0.05, we discarded all the genes that did not contain any pair
of exons with significant di↵erential expression. We then selected only the
genes that showed higher expression in the downstream exon of the first pair
of exons that showed di↵erential expression (DE), thus eliminating genes
whose first exon had more expression than the second, for example). The
first pair with di↵erential expression had to be in the beginning of the gene to
avoid selecting genes with DE in one of the last exons (thus not correspond-
ing to genes with ITI). For this, we selected only the genes whose first pair
of exons with di↵erential DE was located in the first 40% of exons of that
gene. Moreover, we selected only the genes with stable expression levels in
the downstream exons. For this, we assumed that no more than 50% of the
p-values detected by our method were below the 0.05 level of significance.
After gene selection, we matched the gene tags to gene names and ob-
tained lists of the identified genes with ITI for each sample.
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Results
Using the two proportion comparison test repeated over every pair of con-
secutive exons in a gene along with the Benjamini-Hochberg procedure for
p-value correction, we identified very few genes (<12) with suspected ITI
(Table 3.4). These correspond to a total of 20 uniquely identified genes from
the six samples.
Table 3.4: Genes with intragenic transcription initiation using
the two proportions comparison test. The first column indicates
the number of genes detected for each sample. The second column corre-
sponds to the genes identified with the same method without making any
restrictions regarding the expression levels of the downstream exons.
.
Sample Number of identified genes Number of detected genes without downstream exon expression restrictions
Caki1 9 214
Caki2 5 189
AB 3 90
ER 2 53
MF 9 279
FG2 11 346
Since our criteria to include a gene in the set of genes with ITI was
relatively stringent regarding the expression of the exons downstream of the
first expressed exon, we considered all the genes detected regardless of the
expression levels of the downstream exons (Table 3.4). The number of genes
represented in the second column of the table corresponds to the maximum
number of genes that can potentially have ITI as detected by this method.
However, some of these genes may not correspond to genes with ITI but to
alternative spliced forms instead.
Whitin this larger group, 382 unique genes can be identified. This is a
very small number as compared to the results of Grosso et al., 2013 where
1037 genes were identified after applying Fisher’s exact test as described in
Carvalho et al., 2013. The concordance between this method and the imple-
mentation of the two proportion comparison test is negligible with  2 genes
being concordant in several comparisons. We hypothesized that this di↵er-
ence could have occured because the data was transformed into proportions.
Therefore, we compared these results with those obtained when we apply
the Maracuilo procedure (described below). Once again, the concordance
was negligible.
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3.3.2 The Marascuilo procedure
Implementing the Marascuilo procedure
Analogously to the two proportion comparison test, we applied the Maras-
cuilo procedure to compare pairs of exons in every gene. This procedure
makes every pair-wise comparison of exons in each gene as opposed to the pre-
vious procedure where the number of comparisons is the number of exons 1.
For a gene with j exons, jC2 comparisons are performed and a p-value is ob-
tained for each. Our goal, however, is to consider only the comparisons
between contiguous exons and, therefore, selection of the relevant pair-wise
comparisons was made. The Marascuilo procedure incorporates correction
for multiplicity thus not requiring the use of the Benjamini-Hochberg proce-
dure or other method of p-value correction.
Selecting only the comparisons of interest can be performed because it
does not bias the results towards the alternative hypothesis. In fact, perform-
ing multiple testing p-value correction for more pairs of proportions than we
are interested in, increases the p-values thus biasing the conclusions towards
H0 (more conservative test).
Like in the previous method, we selected the genes that showed signif-
icant higher expression in a downstream exon (considering ↵ = 0.05) and
defined that no more than 50% of the p-values in the downstream compar-
isons analyzed were below the 0.05 level of significance. After selecting the
pairs of comparisons of interest we filtered our results to the two proportion
comparison test and matched the gene tags to gene names and obtained lists
of the identified genes with ITI for each sample.
Results
Using the Marascuilo procedure, we identified, approximately, 500 genes per
sample with suspected ITI (Table 3.5):
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Table 3.5: Genes with intragenic transcription initiation using
the Marascuilo procedure. The first column corresponds to the num-
ber of genes detected for each sample. The second column corresponds
to the genes identified for each sample and that are not contained in the
Caki1 (control) sample.
Sample Marascuilo Procedure - Number of identified genes Number of genes detected excluding intersection with Caki1
Caki1 514 -
Caki2 517 208
AB 541 287
ER 490 299
MF 492 298
FG2 526 259
These counts correspond to a total of 1304 di↵erent genes identified since
there is considerable gene overlap between samples. This overlap is illustrated
in the Venn Diagrams in Figure 3.2. The diagrams show that even though
there is a similar number of genes detected for each sample, there are more
genes detected in the mutated cell lines: first, when we exclude from Caki2
and the four mutant lines the genes that are also detected in Caki1, we
observe that each of the mutated cell lines has near 300 genes with intragenic
initiation as opposed to Caki2 that shows only 208 genes (Table 3.5); second,
when we analyze Figure 3.2 b, we observe that there are 583 di↵erent genes
in the 4 mutant cell lines which corresponds to an average of 146 separate
genes per sample. In the controls there are 223 genes detected that are
not detected in the mutant cell line which corresponds to an average of 112
genes per sample. Even though this is a small di↵erence, it suggests that the
SETD2 mutant cell lines have, on average, more ITI than the controls. Note
that in table 3.5 we consider Caki1 as baseline and compare the di↵erences
between the other five cell lines after extracting the genes these have in
common with Caki1. This is meant to make our results comparable to those
obtained by the method described in Carvalho et al., 2013.
31
Chapter 3. Method Description and Results
Figure 3.2: Venn diagrams of genes with Intragenic initiation.
a. Genes identified in the 2 control groups: Caki1 and Caki2. b. Genes
identified in the set of control cell lines vs. the set of all genes identified in
a mutant cell line. c. Gene overlap between the controls and the 4 mutant
cell lines. d. Gene overlap between the four mutant cell lines.
Our results also show that ITI most often starts in the second exon (77.7%
of the identified genes in the mutated cell lines) as is shown in Figure 3.3. This
is in agreement with the results by Grosso et al., 2013 where the second exon
was also the most common site on intragenic transcription initiation (36%
of the detected genes). This di↵erence is attributable to the constraints we
added for the first exon where transcription started to be in the first 40% of
exons in each gene.
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Figure 3.3: Bar plot of intragenic initiation site location.The x-
axis represents the exon at which transcription starts. Approximately 78%
of genes with ITI start transcription at the second exon.
We had access to the list of genes with ITI detected by Grosso et al., 2013
and compared our results to the one obtained by their method (Carvalho et
al., 2013). Overall, we detected a similar number of genes with ITI: 1304
genes vs. 1037 genes detected by Grosso et al., 2013. If we exclude the genes
identified by our method in the controls Caki1 and Caki2 (which are not de-
tected using Fisher’s exact test), we identify 583 genes (Figure 3.2 b). This
is in agreement with our predictions since the Marascuilo procedure is ex-
pectedly more conservative than Fisher’s exact test because more hypothesis
are tested thus leading to a smaller number of detected genes.
Moreover, we assesed the concordance between the mutant cell lines be-
tween the two methods. We verify that the concordance is relativelly small.
For the samples AB, ER, MF and FG2 the concordance between methods
is 3.0%, 6.3%, 4.5% and 12.7%, respectively (Figure 3.4). On the contrary,
when we compare the intra-SETD2 mutated cell line concordance (Figure
3.2 d) with the similar diagram built by Grosso et al., 2013, we verify that
our mutated cell lines have 123 concordant genes between the four samples
(vs. 9 genes in Grosso et al., 2013). The same is apparent with the 2 and 3
mutant cell line concordance. Grosso et al. detected 1037 genes with 22.3%
of genes shared among at least 2 of the 4 SETD2 deficient cell lines. In our
case, the same concordance was in the order 52.3% which suggest that our
method generates more consistent results.
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Figure 3.4: Venn diagrams - Marascuilo procedure-based
method vs. Carvalho et al. method. Venn diagrams of the inter-
section between the Marascuilo procedure-based method and the method
described by Carvalho et al., 2013.
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Discussion
In this manuscript, we applied two statistical methods to detect intragenic
initiation using high-throughput sequencing data. Both methods were based
on transforming count data into proportions and applying tests that allowed
comparison of multiple proportions.
In this work, an emphasis was put on the statistical methodology and
the initial processing of RNA-seq was performed in a relatively standard and
straightforward way. It should, however, be acknowledged that there are
also several methods of processing NGS data and that this is a very active
research field. Every step in the NGS data analysis workflow, from mapping
to alignment, summarization and normalization is undergoing improvements
with the development of new and more accurate tools for data processing.
These are meant to improve the quality of the data and reflect on the quality
of the conclusions that can be derived from it.
Regarding the statistical methodology, the main focus of this work was to
create a method that would detect the phenomenon of intragenic initiation by
comparing the read counts obtained in four samples of ccRCC SETD2 knock-
down cell lines and compare them with 2 normal controls. Even though NGS
data is count data, we transformed our variables and obtained proportions
based on the normalized read counts and the expected reads counts for each
gene assuming that every each is equally active. However, using proportions
in this way carries the problem that some genes that are expression outliers
have at least one pair of exons with proportions greater than 1 which does
not allow these genes to be included in the analysis. Nevertheless, this is not
a major limitation of the method since the the number of genes in this group
corresponds to less than 0.05% of the analyzed genes.
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The main di↵erence between our approaches and the one applied by Car-
valho et al., 2013 was that we did not use direct comparison between mutant
cell lines and controls to detect intragenic initiation, that is, controls are not
used as a baseline and the method identifies the di↵erences between controls
and mutant cell lines. This is relevant because: (1) intragenic initiation may
already occur in cells with a wild-type SETD2 gene and (2) the SETD2 gene
may be a driver of ITI or it may change the genes pattern that has intragenic
initiation. By using controls as baseline, the di↵erence suggested in (2) can-
not be assessed. In contrast, using exon expression comparisons within each
gene to identify ITI permits identification of which genes in a sample show a
pattern of ITI. In this fashion, it is possible to define which genes have ITI
in the controls and then compare with the mutant cell lines. In fact, the re-
sults obtained are more suggestive of (2) as opposed to (1) since the number
of genes detected using the Marascuilo procedure was similar across the six
samples. However, when we compare Caki2 and the four mutant cell lines
with Caki1 as is performed in Carvalho et al., 2013 and Grosso et al., 2013,
we verify that there are more genes with intragenic initiation in the mutant
samples which is suggestive of (1). We attribute the smaller di↵erence than
the one encountered by Grosso et al., 2013 to the conservativeness of the
Marascuilo procedure.
The two proportion comparison method approach yielded very few genes
as compared to the Marascuilo procedure even though the later is a more
conservative test. We hypothesized that this significant di↵erence was due
to the detection of small fluctuations in exon expression by this method.
In fact, if we relax the assumptions do define ITI, we detect more genes
(Table 3.4). However, the absence of intersection of these genes with the
results obtained with the Marascuilo procedure and by Grosso et al., 2013
is remarkable. A possible explanation for this is the detection of excessive
noise in each gene that interferes with the detection of the genes with ITI.
When we applied the two proportions comparison test, we first used the
grouped Benjamini-Hochberg procedure to respect the group structure in
the data: exons-genes-genome. Given the large number of groups (approxi-
mately 20, 000, corresponding to the number of genes analyzed), we were not
able to detect any di↵erences in expression since we could never reject H0 in
any of the comparisons. For this reason, we applied the Benjamini-Hochberg
procedure and assumed independence between genes in each sample which
is similar to the procedure applied by Carvalho et al., 2013. This does not
explain the small number of genes detected since not considering group struc-
ture is less conservative than considering a group structure. Therefore, this
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procedure should detect more genes as opposed to the application of the
grouped Benjamini-Hochberg procedure.
The Marascuilo procedure-based methodology seems to be able to detect
genes with intragenic initiation even though there was a weak concordance
between our results and results previously described (Grosso et al., 2013).
The di↵erences encountered are attributable to the selection criteria that
each method uses. Particularly, in our case we are stringent about the posi-
tion of the first di↵erentially expressed exon and the number of di↵erentially
expressed exons downstream of the first expressed exon.
The restrictions imposed on the number of di↵erentially expressed con-
secutive exons downstream of the first spot where DE was detected are of
particular importance. In particular, when we consider the method of Car-
valho et al., 2013, the restriction is put on 60% of downstream exons having
di↵erential expression comparing to the control. In our approach, our main
goal is to identify genes that have only one pair of di↵erentially expressed
exons. In short, the previously described method aims to identify genes with
a high proportion of true alternative-hypotheses whereas we aim to identify
genes with a high proportion of true-null hypotheses. We hypothesize that
this is the main reason for the di↵erences in our results. Additionally, data
processing of the data was performed di↵erently between our methods and
Carvalho et al., in particular regarding criteria for gene exclusion. In our
approach a gene was considered active if the reads counts were above the
first tercile whereas in Carvalho et al. exclusion is based on a fixed read
count threshold.
While the method we applied based on the Marascuilo procedure per-
forms p-value correction for multiple testing, it does not take into account
the hierarchical group structure of exon-gene-genome. It corrects p-values for
each pair-wise comparison at the gene level but assumes no group structure
at the gene level. In addition, the Maracuilo procedure performs all possible
pair-wise comparisons between the exons of each gene instead of the com-
paring only the consecutive exons. This biases our conclusions towards the
non-rejection of the hypothesis that a gene has ITI, decreases the amount
of genes detected by the method and, possibly, the amount of genes that
overlap with the results obtained by Grosso et al., 2013.
The use of RNA-seq data to detect phenomena like ITI can be used in two
ways: (1) to evaluate the impact of genetic alterations in the pattern of ITT,
which is the goal in our case or (2) as a survey method to identify specific
genes that have intragenic initiation and that required further exploration.
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In the first, ITI can be studied either in one sample or to compare di↵erent
samples. In fact, we propose the experiment of comparing several sequencing
data from the same cell line and evaluate the variation in results using the
same method in order to be able to estimate the variability of the data.
Only with this estimate it is possible to accurately evaluate if the di↵erences
encountered between methods are to be expected or not.
In summary, this work had the main goal of creating a procedure to
identify ITI in SETD2 deficient cells. Nevertheless, this can be generalizable
to detect intragenic initiation using RNA-seq data regardless of the gene
whose function is to be elucidated. Given that our approach encompasses
detection of ITI within a sample without comparing against a baseline, it can
be . We propose the use of the Marascuilo procedure as a method to detect
ITI in other settings and suggest the creation of more specific criteria to define
that a gene had ITI in order to more accurately detect this phenomenon.
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Appendix A
R Scripts
The scripts corresponding to the data processing steps and the implementa-
tion of the two methods tested are shown below. The same procedure was
run for each of the five remaining samples. Given that RNA-seq contains a
lot of information and occupies a lot of memory space, the three scripts take
several hours to run in a standard laptop/desktop computer. In particular,
the data processing takes ⇡ two hours to run while the two proportion com-
parison test and the Marascuilo procedure take ⇡1.5 hours each per sample
in an Apple MacBook Pro laptop.
A.1 Data processing
#------------------DATA PROCESSING-------------------
#Reading the .bed data files
fileList<-
c("readsPerExon_rcc_caki1.bed","readsPerExon_rcc_caki2.bed","readsPerEx
on_rcc_ab.bed","readsPerExon_rcc_er.bed","readsPerExon_rcc_mf.bed","rea
dsPerExon_rcc_fg2.bed")
for(i in 1:length(fileList)){
assign(paste("data",i,sep=""),read.table(fileList[i], header=F))
}
#Gene list (with gene names)
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geneList<-as.matrix(read.table("HumanGenes_hg19.txt", header=F))
geneDic<-cbind(geneList[,2],geneList[,13])
#Total number of mapped and unmapped reads per sample
totalReads<-read.table("totTagsNr.txt",header=T)
caki1.totalReads<-totalReads[6,3]
caki2.totalReads<-totalReads[7,3]
rccab.totalReads<-totalReads[3,3]
rccer.totalReads<-totalReads[1,3]
rccmf.totalReads<-totalReads[2,3]
rccfg2.totalReads<-totalReads[5,3]
#----------------------------------------------------------
# Calculating exon length
exon.length<-data[,3]-data[,2] #Based on the data from Caki1
#Altering the matrix to separate genes and exons
library(stringr)
genEx<-str_split_fixed(data[,4], "_", 8)
genExMerge<-c(paste(genEx[,1],genEx[,2],sep="_"))
genEx2<-str_split_fixed(data2[,4], "_", 8)
genEx3<-str_split_fixed(data3[,4], "_", 8)
genEx4<-str_split_fixed(data4[,4], "_", 8)
genEx5<-str_split_fixed(data5[,4], "_", 8)
genEx6<-str_split_fixed(data6[,4], "_", 8)
#----------------------------------------------------------
caki1<-data.frame(genExMerge,genEx[,4],genEx[,6],
data[,7])
colnames(caki1)<-c("gene","exon","chromossome",
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"caki1")
caki2<-data.frame(genExMerge,genEx2[,4],genEx2[,6],
data2[,7])
colnames(caki2)<-c("gene","exon","chromossome",
"caki2")
rccab<-data.frame(genExMerge,genEx3[,4],genEx3[,6],
data3[,7])
colnames(rccab)<-c("gene","exon","chromossome",
"rccab")
rccer<-data.frame(genExMerge,genEx4[,4],genEx4[,6],
data4[,7])
colnames(rccer)<-c("gene","exon","chromossome",
"rccer")
rccmf<-data.frame(genExMerge,genEx5[,4],genEx5[,6],
data5[,7])
colnames(rccmf)<-c("gene","exon","chromossome",
"rccmf")
rccfg2<-data.frame(genExMerge,genEx6[,4],genEx6[,6],
data6[,7])
colnames(fg2)<-c("gene","exon","chromossome",
"rccfg2")
full<-data.frame(genExMerge,genEx[,4],genEx[,6],data[,7],
data2[,7],data3[,7],data4[,7],data5[,7],data6[,7])
colnames(full)<-c("gene","exon","chromossome",
"caki1","caki2","rccab","rccer","rccmf","rccfg2")
#----------------------------------------------------------
#Matching gene names with gene tags
geneTag<-paste(genEx[,1],genEx[,2],sep="_")
uni.geneDic<-geneDic[which(duplicated(geneDic[,1])==FALSE),]
matched<-rep(NA, times=nrow(myData)) #Genes with no gene tag will
remain as NA
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for (i in 1:length(geneTag)){
if (geneTag[i] %in% uni.geneDic==TRUE){
matched[i]<-uni.geneDic[which(geneTag[i]==uni.geneDic[,1]),2]
print(i)
}
}
#----------------------------------------------------------
#Wrote .CSV and re-read it to be able to work with the data
myData<-cbind(full,matched)
write.csv(myData, "table.csv")
#To re-read data
myData0<-read.csv("table.csv", header=T, sep=",")
myData0<-myData0[,2:11]
colnames(myData0)<-c("gene","exon","chromossome",
"caki1","caki2","rccab","rccer","rccmf","rccfg2","matched")
#----------------------------------------------------------
#Index to distinguish genes (one number for each gene)
#index2
index2<-c(rep(1,1,nrow(myData0)))
for (i in 1:nrow(myData0)){
if (myData0$exon[i+1]>myData0$exon[i]) {index2[i+1]=index2[i]}
else
index2[i+1]=index2[i]+1
}
#Exons per gene
myData.exon<-myData0$exon+1
exon.number<-
unlist(tapply(myData.exon,index2,FUN=function(myData.exon){max(myData.e
xon)}))
head(exon.number)
exon.number2<-cbind(unique(index2),exon.number)
#----------------------------------------------------------
##Removing the genes composed of 4 or less exons
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#To identify genes composed of 1 exon
single.exon<-vector()
for (i in 1:(nrow(myData0)-1)){
if(myData0$exon[i+1]==myData0$exon[i]){
single.exon<-c(single.exon,index2[i])
}
}
removeSingleExon<-rep(1,times=nrow(myData))
for(i in 1:nrow(myData0)){
if(length(which((index2[i]==single.exon)==TRUE))==0){
removeSingleExon[i]=0
}
}
myData1<-myData0[-which(removeSingleExon==1),]
exon.length1<-exon.length[-which(removeSingleExon==1)]
index2.1<-index2[-which(removeSingleExon==1)]
#--------
#To identify genes composed of 4 or less exons
smallGene<-vector()
exon<-myData1$exon
s<-unlist(tapply(exon,index2.1,
FUN=function(exon){if(max(exon)<4) s<-index2.1[exon[max(exon)+1]]}))
head(s)
smallGene<-as.numeric(names(s))
#To verify that the genes to remove are correct (optional)
#v<-vector()
#for(i in 1:length(smallGene)){
#v<-c(v,length(which(index2.1==smallGene[i])))
#}
#To expand the vector with the small genes
removeSmallGenes<-rep(1,times=nrow(myData1))
for(i in 1:nrow(myData1)){
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if(length(which((index2.1[i]==smallGene)==TRUE))==0){
removeSmallGenes[i]=0
}
}
myData2<-myData1[-(which(removeSmallGenes==1)),]
exon.length2<-exon.length1[-(which(removeSmallGenes==1))]
index3<-index2.1[-(which(removeSmallGenes==1))]
#---------------------------------------------------------------------
#To select transcriptionally active genes
#####caki1
caki1.sum<-myData2$caki1
caki1.sumReadsPerGene<-unlist(tapply(caki1.sum,index3,
FUN=function(caki1.sum){sum(caki1.sum)}))
quantile(caki1.sumReadsPerGene,1/3) #cutoff to consider a gene active
#Inactive genes
caki1.inactiveGenes<-
which(caki1.sumReadsPerGene<quantile(caki1.sumReadsPerGene,1/3))
#Expading the inactiveGenes vector according to the index
caki1.removeExons<-rep(1,times=length(caki1.sum))
for(i in 1:length(caki1.sum)){
if(length(which((index3[i]==caki1.inactiveGenes)==TRUE))==0){
caki1.removeExons[i]=0
}
}
#Removing the genes
caki1.final<-caki1.sum[-(which(caki1.removeExons==1))]
caki1.myData3<-myData2[-(which(caki1.removeExons==1)),]
caki1.exon.length3<-exon.length2[-(which(caki1.removeExons==1))]
caki1.index4<-index3[-(which(caki1.removeExons==1))]
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#----------------------------------------------------------
#To standardize the data
caki1.norm<-
(caki1.final)/((caki1.exon.length3/1000)*((caki1.totalReads)/1000000))
#----------------------------------------------------------
#Estimating the reads based only on the more active genes
#caki1
quantile(caki1.sumReadsPerGene,2/3) #cutoff to consider a gene VERY
active
caki1.lessActiveGenes<-
which(caki1.sumReadsPerGene<quantile(caki1.sumReadsPerGene,2/3))
#Expanding the less active genes vector
caki1.lessActiveExons<-rep(1,times=length(caki1.norm))
for(i in 1:length(caki1.norm)){
if(length(which((caki1.index4[i]==caki1.lessActiveGenes)==TRUE))==0){
caki1.lessActiveExons[i]=0
}
}
caki1.totalReads.vector<-
rep(caki1.totalReads,times=length(exon.length))
caki1.totalReads.activeGenes<-caki1.totalReads.vector[-
which(removeSingleExon==1)]
caki1.totalReads.activeGenes1<-caki1.totalReads.activeGenes[-
(which(removeSmallGenes==1))]
caki1.totalReads.activeGenes2<-caki1.totalReads.activeGenes1[-
(which(caki1.removeExons==1))]
caki1.totalReads.activeGenes3<-caki1.totalReads.activeGenes2[-
(which(caki1.lessActiveExons==1))]
caki1.exonLengthForEstim<-caki1.exon.length3[-
(which(caki1.lessActiveExons==1))]
#Estimated number of reads after gene exclusion (both inactive gene and
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less active genes (bottom 2/3 of the active genes))
caki1.estimReadsPerExon<-
(caki1.totalReads.activeGenes3/length(caki1.exonLengthForEstim))*caki1.
exonLengthForEstim
#Standardize estimReads - confirm
caki1.estimReadsPerExon.norm<-
(caki1.estimReadsPerExon)/((caki1.exonLengthForEstim/1000)*((caki1.tota
lReads)/1000000))
#Denominator for vector with proportions
caki1.estimReadsPerExon.norm.final<-
rep(caki1.estimReadsPerExon.norm[1],times=length(caki1.norm))
#Vector with proportions
caki1.propVector<-caki1.norm/caki1.estimReadsPerExon.norm.final
#Identifying genes with proportions>1
caki1.myData4<-cbind(caki1.myData3,caki1.index4)
#Index of genes with proportions>1
caki1.prop1.index<-
unique(caki1.myData4$caki1.index4[which(caki1.propVector>1)])
#Expanding the vector according of indexes of genes with proportions>1
to isolate
caki1.prop1.remove<-rep(1,times=nrow(caki1.myData4))
for(i in 1:nrow(caki1.myData4)){
if(length(which((caki1.myData4$caki1.index4[i]==caki1.prop1.index)==TRU
E))==0){
caki1.prop1.remove[i]=0
}
}
#Removing those genes of the data matrix and passing them to the
caki1.prop1.matrix
caki1.myData5<-caki1.myData4[-which(caki1.prop1.remove==1),]
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#Matrix with only the genes with proportions bigger than 1
caki1.myData5.propBig1<-caki1.myData4[-which(caki1.prop1.remove!=1),]
#---------------------------------------------------------
#Adjusting Estim reads count and proportion vector without propBig
#eliminated the normalized read counts pertaining to genes with
proportions >1
caki1.norm2<-caki1.norm[-which(caki1.prop1.remove==1)]
#Expanding the less active genes vector for propBig
caki1.lessActiveExons.propBig<-rep(1,times=length(caki1.norm2))
for(i in 1:length(caki1.norm2)){
if(length(which((caki1.myData5$caki1.index4[i]==caki1.lessActiveGenes)=
=TRUE))==0){
caki1.lessActiveExons.propBig[i]=0
}
}
#Total reads for propBig
caki1.totalReads.activeGenes4<-
rep(caki1.totalReads.activeGenes3[1],times=length(caki1.exonLengthForEs
tim.propBig))
caki1.exon.length4<-caki1.exon.length3[-which(caki1.prop1.remove==1)]
caki1.exonLengthForEstim.propBig<-caki1.exon.length4[-
(which(caki1.lessActiveExons.propBig==1))]
#Estimated number of reads after gene exclusion (both inactive gene and
less active genes (bottom 2/3 of the active genes))
caki1.estimReadsPerExon.propBig<-
(caki1.totalReads.activeGenes4/length(caki1.exonLengthForEstim.propBig)
)*caki1.exonLengthForEstim.propBig
#Standardize estimReads
caki1.estimReadsPerExon.propBig.norm<-
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(caki1.estimReadsPerExon.propBig)/((caki1.exonLengthForEstim.propBig/10
00)*((caki2.totalReads)/1000000))
#Denominator for vector with proportions
caki1.estimReadsPerExon.propBig.norm.final<-
rep(caki1.estimReadsPerExon.propBig.norm[1],times=length(caki1.norm2))
#Vector with proportions for analysis
caki1.propVector2<-
caki1.norm2/caki1.estimReadsPerExon.propBig.norm.final
A.2 Two proportions comparison test with
the grouped BH correction for multiple
testing
#--------------TWO PROPORTIONS COMPARISON TEST-------------
#1st vector - removing the last exon of each gene
#First, creating a vector with the number of exons of each
gene
caki1.combinProp<-
as.vector(tapply(caki1.myData5$exon,caki1.myData5$caki1.ind
ex4,max))+1
caki1.maxPosition<-rep(0,1,length(caki1.combinProp))
caki1.maxPosition[1]<-caki1.combinProp[1]
for(i in 1:(length(caki1.combinProp)-1)){
caki1.maxPosition[i+1]<-
caki1.maxPosition[i]+caki1.combinProp[i+1]
}
#1st vector of proportions (without the last exon of each
gene)
caki1.prop1<-caki1.propVector2[-caki1.maxPosition]
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#2nd vector of proportions (without the first exon of each
gene)
caki1.prop2<-caki1.propVector2[-
which(caki1.myData5$exon==0)]
#----------------------------------------------------------
#2 proportions comparison test
caki1.zStat<-rep(0,length(caki1.prop1))
caki1.pValue<-rep(0,length(caki1.prop1))
#Creating the vector with the adequate length os estimated
reads for Z-stat calculation
caki1.estimReadsPerExon.norm.zStat<-
rep(caki1.estimReadsPerExon.norm[1],times=length(caki1.prop
1))
#Calculating the Z-Stat
for(i in 1:length(caki1.prop1)){
caki1.zStat[i]<-(caki1.prop1[i]-
caki1.prop2[i])/(sqrt((caki1.prop1[i]*(1-
caki1.prop1[i])/caki1.estimReadsPerExon.norm.zStat[i])+(cak
i1.prop2[i]*(1-
caki1.prop2[i])/caki1.estimReadsPerExon.norm.zStat[i])))
if(caki1.prop1[i]==0 & caki1.prop2[i]==0){
caki1.zStat[i]=2.2e-16
}
}
#Calculating the p-value
caki1.pValue<-2*(1-pnorm(abs(caki1.zStat)))
#----------------------------------------------------------
#Index for prop.test
caki1.group0<-caki1.myData5$caki1.index4[-
caki1.maxPosition]
caki1.group<-rep(0,times=length(caki1.group0))
for (i in 1:(length(caki1.group0)-1)){
if (caki1.group0[i]!=caki1.group0[i+1]){
caki1.group[i+1]=0
}
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else {caki1.group[i+1]=caki1.group[i]+1}
}
#----------------------------------------------------------
#Adjusting the p-value - Grouped Benjamini-Hochberg method
#library(structSSI)
caki1.pValueAdjGBH<-
Adaptive.GBH(caki1.pValue,caki1.group,alpha=0.05,method="ls
l")
#Creating output matrix
caki1.c2<-
c(as.numeric(caki1.pValueAdjGBH$rejected),as.numeric(caki1.
pValueAdjGBH$not.rejected))
caki1.c3<-caki1.pValueAdjGBH$adjp
caki1.c4<-cbind(caki1.c2,caki1.c3)
caki1.ordered<-caki1.c4[order(caki1.c4[,1]),]
caki1.gbh.matrix<-
cbind(caki1.group0,caki1.propTestStr,caki1.ordered[,1],caki
1.ordered[,1]+1,caki1.zStat,caki1.pValue)
#---------------------------------------------------------
#Adjusting the p-value - Benjamini-Hochberg method
caki1.pValueAdj<-unlist(tapply(caki1.pValue,caki1.group0,
FUN=function(caki1.pValue){p.adjust(caki1.pValue,method="ho
chberg")}))
#Creating the output matrix
#Vector with binary significance (p-value=0.05)
caki1.prop.significance<-rep(0,length(caki1.pValueAdj))
for (i in 1:length(caki1.pValueAdj)){
if(caki1.pValueAdj[i]<0.05)
caki1.prop.significance[i]<-1
}
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#Creates a string vector with the exon comparisons
#Vector for each exon
caki1.propTestStr<-paste("exon",caki1.group, " vs.
","exon",caki1.group+1,sep = " ")
head(caki1.propTestStr)
#Expression difference between pairs of exons
caki1.expressionDiff<-
as.vector(unlist(tapply(caki1.propVector2,caki1.myData5$cak
i1.index4,
FUN=function(caki1.propVector2){combn(caki1.propVector2,2)[
2,]-combn(caki1.propVector2,2)[1,]})))
caki1.bh.output.final<-
cbind(caki1.group0,caki1.propTestStr,caki1.group,caki1.grou
p+1,caki1.zStat,caki1.pValueAdj,caki1.expressionDiff,caki1.
prop.significance)
#Removing genes that do not have any significance=1
caki1.bh.sig<-as.numeric(caki1.bh.output.final[,8])
caki1.bh.sigSum<-
as.vector(unlist(tapply(caki1.bh.sig,as.numeric(caki1.bh.ou
tput.final[,1]),FUN=function(caki1.bh.sig){sum(caki1.bh.sig
)})))
caki1.bh.noItiGenes<-unique(caki1.bh.output.final[,1])[-
which(caki1.bh.sigSum>0)]
caki1.bh.iti.output<-caki1.bh.output.final[-
which(caki1.bh.output.final[,1] %in% caki1.bh.noItiGenes),]
#Number of exons in each of the selected genes
exonNum.bh.iti.index<-as.numeric(caki1.bh.iti.output[,4])
exonNum.bh.iti<-
as.vector(unlist(tapply(exonNum.bh.iti.index,as.numeric(cak
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i1.bh.iti.output[,1]),FUN=function(exonNum.bh.iti.index){ma
x(exonNum.bh.iti.index)})))
#Expanding the number of exons vector to fit the output
matrix
exonNum.bh.iti.exp<-c()
for (i in 1:length(exonNum.bh.iti)){
exonNum.bh.iti.exp<-
c(exonNum.bh.iti.exp,rep(exonNum.bh.iti[i],times=exonNum.bh
.iti[i]))
}
caki1.bh.iti.output2<-
cbind(caki1.bh.iti.output,exonNum.bh.iti.exp)
head(caki1.bh.iti.output2)
#Selecting only the entries with significance=1
caki1.bh.iti.output3<-
caki1.bh.iti.output2[which(as.numeric(caki1.bh.iti.output2[
,8])==1),]
#Index for the first significance significance entry
caki1.bh.first.sig<-rep(1,times=nrow(caki1.bh.iti.output3))
for (i in 1:(length(caki1.bh.first.sig)-1)){
if(as.numeric(caki1.bh.iti.output3[i+1,1])==as.numeric(caki
1.bh.iti.output3[i,1])){
caki1.bh.first.sig[i+1]<-0
}
}
#Updating the output with the first.sig vector
caki1.bh.iti.output4<-
cbind(caki1.bh.iti.output3,caki1.bh.first.sig)
#Excluding the cases where the expression difference is
negative & first.sig=1
#--------Gene indexes to eliminate
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caki1.bh.elimGene.index<-
as.numeric(caki1.bh.iti.output4[which(as.numeric(caki1.bh.i
ti.output4[,7])<0 & caki1.bh.first.sig==1),1])
caki1.bh.iti.output5<-caki1.bh.iti.output4[-
which(as.numeric(caki1.bh.iti.output4[,1]) %in%
caki1.bh.elimGene.index),]
#Eliminating first.sig
#caki1.elimGene.index2<-as.numeric()
caki1.bh.first.sig2<-
rep(1,times=nrow(caki1.bh.iti.output5))
for(i in 1:(nrow(caki1.bh.iti.output5)-1)){
if(as.numeric(caki1.bh.iti.output5[i+1,1])!=as.numeric(caki
1.bh.iti.output5[i,1]) &
as.numeric(caki1.bh.iti.output5[i+1,10])==0){
caki1.bh.first.sig2[i+1]<-0
}
}
#Addind total number of exons to the output matrix
caki1.bh.exon.number.iti<-c()
for (i in 1:nrow(caki1.bh.iti.output5)){
if (as.numeric(caki1.bh.iti.output5[i,1]) %in%
exon.number2[,1]){
caki1.bh.exon.number.iti[i]<-
exon.number2[which(exon.number2[,1]==which(exon.number2[,1]
%in% as.numeric(caki1.bh.iti.output5[i,1]))),2]
}
}
caki1.bh.iti.output6<-
cbind(caki1.bh.iti.output5,caki1.bh.exon.number.iti)
#cutoff
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caki1.bh.cutoff<-(as.numeric(caki1.bh.iti.output6[,11])-
as.numeric(caki1.bh.iti.output6[,4]))/as.numeric(caki1.bh.i
ti.output6[,11])
caki1.bh.cutoff.index<-
caki1.bh.iti.output6[which(caki1.bh.iti.output6[,10]==1 &
caki1.bh.cutoff>0.6),1]
caki1.bh.iti.output7<-
caki1.bh.iti.output6[which(as.numeric(caki1.bh.iti.output6[
,1]) %in% as.numeric(caki1.bh.cutoff.index)),]
###########################################################
#######
#Separating simple ITI genes (caki1.iti.genes) from "more
complex" genes (caki1.spec.iti.genes)
caki1.bh.spec.iti.genes.index<-
as.numeric(caki1.bh.iti.output7[which(caki1.bh.iti.output7[
,10]==0),1])
#Only the ones with negative diff expression at at least on
pair of exons
caki1.bh.spec.iti.genes.index.neg<-
unique(caki1.bh.iti.output7[which(caki1.bh.iti.output7[,7]<
0),1])
caki1.bh.iti.genes<-caki1.bh.iti.output7[-
which(as.numeric(caki1.bh.iti.output7[,1]) %in%
unique(caki1.bh.spec.iti.genes.index.neg)),]
caki1.bh.spec.iti.genes<-
caki1.bh.iti.output7[which(as.numeric(caki1.bh.iti.output7[
,1]) %in% unique(caki1.bh.spec.iti.genes.index.neg)),]
head(caki1.bh.spec.iti.genes)
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#Matching the gene names of the detected genes with ITI
#----------New Gene Dictionary
myGeneDic<-cbind(index2,matched)
uni.myGeneDic<-
myGeneDic[which(duplicated(myGeneDic[,1])==FALSE),]
#----------ITI genes (caki1.iti.genes)
caki1.bh.final.match<-rep(NA,
times=nrow(caki1.bh.iti.genes))
for (i in 1:nrow(caki1.bh.iti.genes)){
if (as.numeric(caki1.bh.iti.genes[i,1]) %in%
uni.myGeneDic[,1]==TRUE){
caki1.bh.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.bh.iti.genes[i,1])==un
i.myGeneDic[,1]),2]
}
}
#----------"More complex" genes (caki1.spec.iti.genes)
caki1.bh.spec.final.match<-rep(NA,
times=nrow(caki1.bh.spec.iti.genes))
for (i in 1:nrow(caki1.bh.spec.iti.genes)){
if (as.numeric(caki1.bh.spec.iti.genes[i,1]) %in%
uni.myGeneDic[,1]==TRUE){
caki1.bh.spec.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.spec.iti.genes[i,1])==
uni.myGeneDic[,1]),2]
}
}
caki1.bh.final.match<-rep(NA,
times=nrow(caki1.bh.iti.genes))
for (i in 1:nrow(caki1.bh.iti.genes)){
if (as.numeric(caki1.bh.iti.genes[i,1]) %in%
uni.myGeneDic[,1]==TRUE){
caki1.bh.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.bh.iti.genes[i,1])==un
i.myGeneDic[,1]),2]
}
}
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A.3 Marascuilo Procedure
#------------------MARASCUILO PROCEDURE-------------------
#Test statistic
caki1.testStat<-
unlist(tapply(caki1.propVector2,caki1.myData5$caki1.index4,
FUN=function(caki1.propVector2)
{abs(combn(caki1.propVector2,2)[1,]-combn(caki1.propVector2,2)[2,])}))
#Critical values calculation (rij)
#Combinations of propVector
caki1.combin<-
as.vector(tapply(caki1.myData5$exon,caki1.myData5$caki1.index4,max))+1
caki1.combinTotal<-cbind(caki1.combin,(caki1.combin*(caki1.combin-
1))/2)
#Vector corresponding to p1*(1-p1)/estRead
caki1.prop<-abs(caki1.propVector2*(1-
caki1.propVector2)/caki1.estimReadsPerExon.propBig.norm.final)
#Degrees of Freedom
caki1.degFreedom<-caki1.combinTotal[,1]-1
caki1.degFreedomExp<-rep(caki1.degFreedom,times=caki1.combinTotal[,2])
#Confidence level
confidence<-.95
#Computes the critical range value
caki1.range1<-sqrt(qchisq(confidence,caki1.degFreedomExp))
caki1.range2<-unlist(tapply(caki1.prop,caki1.myData5$caki1.index4,
FUN=function(caki1.prop){sqrt(combn(caki1.prop,2)[1,]+combn(caki1.prop,
2)[2,])}))
caki1.range<-caki1.range1*caki1.range2 #final
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#Establishing significance (test statistic > critical value)
caki1.significance<-rep(0, length(caki1.testStat))
for (i in 1:length(caki1.testStat)){
if(caki1.testStat[i]>caki1.range[i]) caki1.significance[i]<-1
}
#Creates a string vector with the exon comparisons
#Vector for each exon
caki1.propStr<-paste("exon",caki1.myData5$exon, sep = "")
#Vector with the sample length according to the index value
caki1.finalPropStr<-
unlist(tapply(caki1.propStr,caki1.myData5$caki1.index4,
FUN=function(caki1.propStr){paste(combn(caki1.propStr,2)[1,],combn(caki
1.propStr,2)[2,], sep=" vs. ")}))
#Expression difference between pairs of exons
caki1.expressionDiff<-
as.vector(unlist(tapply(caki1.propVector2,caki1.myData5$caki1.index4,
FUN=function(caki1.propVector2){combn(caki1.propVector2,2)[2,]-
combn(caki1.propVector2,2)[1,]})))
#Output of Marascuilo Procedure
caki1.output<-
cbind(caki1.finalPropStr,caki1.testStat,caki1.range,caki1.significance)
#Selecting the pairs of interest
caki1.myData5.exon<-caki1.myData5$exon
caki1.myData5.index<-caki1.myData5$caki1.index4
caki1.index<-
as.vector(unlist(tapply(caki1.myData5.index,caki1.myData5.index,
FUN=function(caki1.myData5.index){(combn(caki1.myData5.index,2)[1,])}))
)
head(caki1.index)
caki1.pairs1<-
as.vector(unlist(tapply(caki1.myData5.exon,caki1.myData5$caki1.index4,
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FUN=function(caki1.myData5.exon){(combn(caki1.myData5.exon,2)[1,])})))
caki1.pairs2<-
as.vector(unlist(tapply(caki1.myData5.exon,caki1.myData5$caki1.index4,
FUN=function(caki1.myData5.exon){(combn(caki1.myData5.exon,2)[2,])})))
pairs3<-caki1.pairs2-caki1.pairs1
caki1.pairs4<-caki1.output[,4]
caki1.pairs<-
cbind(caki1.index,caki1.pairs1,caki1.pairs2,pairs3,caki1.pairs4)
#---------Establishing the consecutive pairs
caki1.consecutive.pairs<-rep(0,times=nrow(caki1.pairs))
for (i in 1:nrow(caki1.pairs)){
if(abs(caki1.pairs2[i]-caki1.pairs1[i])==1)
caki1.consecutive.pairs[i]<-1
}
caki1.pairsT<-caki1.pairs[-which(caki1.consecutive.pairs==0),]
caki1.output2<-caki1.output[-which(caki1.consecutive.pairs==0),]
caki1.finalPropStr.pairs<-caki1.finalPropStr[-
which(caki1.consecutive.pairs==0)]
caki1.expressionDiff2<-caki1.expressionDiff[-
which(caki1.consecutive.pairs==0)]
#Final output
caki1.output.final<-
cbind(as.numeric(caki1.pairsT[,1]),caki1.finalPropStr.pairs,caki1.pairs
T[,2:3],as.numeric(caki1.output2[,2]),as.numeric(caki1.output2[,3]),cak
i1.expressionDiff2,as.numeric(caki1.output2[,4]))
colnames(caki1.output.final)<-
c("index","comparisson","exon1","exon2","testStat","range","expressionD
iff","significance")
#Removing genes that do not have any significance=1
caki1.sig<-as.numeric(caki1.output.final[,8])
caki1.sigSum<-
as.vector(unlist(tapply(caki1.sig,as.numeric(caki1.output.final[,1]),FU
N=function(caki1.sig){sum(caki1.sig)})))
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caki1.sigSum[which(unique(caki1.output.final[,1])==139)]
caki1.noItiGenes<-unique(caki1.output.final[,1])[-
which(caki1.sigSum>0)]
caki1.iti.output<-caki1.output.final[-which(caki1.output.final[,1] %in%
caki1.noItiGenes),]
#Number of exons in each of the selected genes
exonNum.iti.index<-as.numeric(caki1.iti.output[,4])
exonNum.iti<-
as.vector(unlist(tapply(exonNum.iti.index,as.numeric(caki1.iti.output[,
1]),FUN=function(exonNum.iti.index){max(exonNum.iti.index)})))
#Expanding the number of exons vector to fit the output matrix
exonNum.iti.exp<-c()
for (i in 1:length(exonNum.iti)){
exonNum.iti.exp<-
c(exonNum.iti.exp,rep(exonNum.iti[i],times=exonNum.iti[i]))
}
caki1.iti.output2<-cbind(caki1.iti.output,exonNum.iti.exp)
#Selecting only the entries with significance=1
caki1.iti.output3<-
caki1.iti.output2[which(as.numeric(caki1.iti.output2[,8])==1),]
#Index for the first significance entry
caki1.first.sig<-rep(1,times=nrow(caki1.iti.output3))
for (i in 1:(length(first.sig)-1)){
if(as.numeric(caki1.iti.output3[i+1,1])==as.numeric(caki1.iti.output3[i
,1])){
caki1.first.sig[i+1]<-0
}
}
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#Updating the output with the first.sig vector
caki1.iti.output4<-cbind(caki1.iti.output3,first.sig)
#Excluding the cases where the expression differecence is negative &
first.sig=1
#--------Gene indexes to eliminate
caki1.elimGene.index<-
as.numeric(caki1.iti.output4[which(as.numeric(caki1.iti.output4[,7])<0
& first.sig==1),1])
caki1.iti.output5<-caki1.iti.output4[-
which(as.numeric(caki1.iti.output4[,1]) %in% caki1.elimGene.index),]
##################################################################
#Addind total number of exons to the output matrix
caki1.exon.number.iti<-c()
for (i in 1:nrow(caki1.iti.output5)){
if (as.numeric(caki1.iti.output5[i,1]) %in% exon.number2[,1]){
caki1.exon.number.iti[i]<-
exon.number2[which(exon.number2[,1]==which(exon.number2[,1] %in%
as.numeric(caki1.iti.output5[i,1]))),2]
}
}
caki1.iti.output6<-cbind(caki1.iti.output5,caki1.exon.number.iti)
caki1.cutoff<-(as.numeric(caki1.iti.output6[,11])-
as.numeric(caki1.iti.output6[,4]))/as.numeric(caki1.iti.output6[,11])
caki1.cutoff2<-rep(0,times=length(caki1.cutoff))
caki1.cutoff2[1]<-caki1.cutoff[1]
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for (i in 1:(caki1.cutoff-1)){
if
(as.numeric(caki1.iti.output6[i+1,1])==as.numeric(caki1.iti.output6[i,1
]))
caki1.cutoff2[i+1]<-caki1.cutoff[i]
}
caki1.cutoff.index<-caki1.iti.output6[which(caki1.iti.output6[,10]==1 &
caki1.cutoff>0.6),1]
caki1.iti.output7<-
caki1.iti.output6[which(as.numeric(caki1.iti.output6[,1]) %in%
as.numeric(caki1.cutoff.index)),]
##################################################################
#Separating simple ITI genes (caki1.iti.genes)
caki1.spec.iti.genes.index<-
as.numeric(caki1.iti.output7[which(caki1.iti.output7[,10]==0),1])
#Only the ones with negative diff expression at at least on pair of
exons
caki1.spec.iti.genes.index.neg<-
unique(caki1.iti.output7[which(caki1.iti.output7[,7]<0),1])
caki1.iti.genes<-caki1.iti.output7[-
which(as.numeric(caki1.iti.output7[,1]) %in%
unique(caki1.spec.iti.genes.index.neg)),]
caki1.spec.iti.genes<-
caki1.iti.output7[which(as.numeric(caki1.iti.output7[,1]) %in%
unique(caki1.spec.iti.genes.index.neg)),]
#Matching the gene names of the detected genes with ITI
#----------New Gene Dictionary
myGeneDic<-cbind(index2,matched)
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uni.myGeneDic<-myGeneDic[which(duplicated(myGeneDic[,1])==FALSE),]
#----------ITI genes (caki1.iti.genes)
caki1.final.match<-rep(NA, times=nrow(caki1.iti.genes))
for (i in 1:nrow(caki1.iti.genes)){
if (as.numeric(caki1.iti.genes[i,1]) %in% uni.myGeneDic[,1]==TRUE){
caki1.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.iti.genes[i,1])==uni.myGeneDic[,1]
),2]
}
}
#----------"More complex" genes (caki1.spec.iti.genes
caki1.spec.final.match<-rep(NA, times=nrow(caki1.spec.iti.genes))
for (i in 1:nrow(caki1.spec.iti.genes)){
if (as.numeric(caki1.spec.iti.genes[i,1]) %in%
uni.myGeneDic[,1]==TRUE){
caki1.spec.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.spec.iti.genes[i,1])==uni.myGeneDi
c[,1]),2]
}
}
#Final gene list
caki1.final.match<-rep(NA, times=nrow(caki1.iti.genes))
for (i in 1:nrow(caki1.iti.genes)){
if (as.numeric(caki1.iti.genes[i,1]) %in% uni.myGeneDic[,1]==TRUE){
caki1.final.match[i]<-
uni.myGeneDic[which(as.numeric(caki1.iti.genes[i,1])==uni.myGeneDic[,1]
),2]
}
}
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